
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152537D88AF1D4A30537D8006C4632EA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="natprobio">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Natural Products and Bioprospecting">
<meta name="citation_title" content="Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy">
<meta name="citation_author" content="Songtao Wu">
<meta name="citation_author_institution" content="Key Laboratory of Chinese Medicine Resources and Compound Formulas, Ministry of Education, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author_institution" content="Hubei Shizhen Laboratory, Wuhan, 430061 China">
<meta name="citation_author" content="Yingying Wang">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Denghui Deng">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Guohua Zheng">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Hanxiang Mei">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Cong Wang">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Xiang Zheng">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Chun Gui">
<meta name="citation_author_institution" content="School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China">
<meta name="citation_author" content="Fei Liao">
<meta name="citation_author_institution" content="Department of Gastroenterology, Wuhan University Renmin Hospital, Wuhan, 430060 China">
<meta name="citation_author" content="Meixian Xiang">
<meta name="citation_author_institution" content="School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074 China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="56">
<meta name="citation_doi" content="10.1007/s13659-025-00540-9">
<meta name="citation_pmid" content="40839202">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/pdf/13659_2025_Article_540.pdf">
<meta name="description" content="Modern pharmacology has found that both Realgar and Coptis chinensis can induce apoptosis in tumor cells, and traditional Chinese medicine theory suggests the possibility of combining the two, however, the specific mechanisms involved have not been ...">
<meta name="og:title" content="Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Modern pharmacology has found that both Realgar and Coptis chinensis can induce apoptosis in tumor cells, and traditional Chinese medicine theory suggests the possibility of combining the two, however, the specific mechanisms involved have not been ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370617">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s13659-025-00540-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13659_2025_Article_540.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370617%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370617/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370617/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-natprobio.gif" alt="Natural Products and Bioprospecting logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Natural Products and Bioprospecting" title="Link to Natural Products and Bioprospecting" shape="default" href="http://link.springer.com/journal/13659" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nat Prod Bioprospect</button></div>. 2025 Aug 21;15(1):56. doi: <a href="https://doi.org/10.1007/s13659-025-00540-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s13659-025-00540-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nat%20Prod%20Bioprospect%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nat%20Prod%20Bioprospect%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Songtao Wu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Songtao Wu</span></h3>
<div class="p">
<sup>1</sup>Key Laboratory of Chinese Medicine Resources and Compound Formulas, Ministry of Education, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">
<sup>3</sup>Hubei Shizhen Laboratory, Wuhan, 430061 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Songtao Wu</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yingying Wang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yingying Wang</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingying Wang</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Denghui Deng</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Denghui Deng</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Denghui Deng</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zheng%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Guohua Zheng</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Guohua Zheng</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zheng%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guohua Zheng</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mei%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Hanxiang Mei</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Hanxiang Mei</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mei%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanxiang Mei</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Cong Wang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Cong Wang</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cong Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zheng%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Xiang Zheng</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Xiang Zheng</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zheng%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiang Zheng</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gui%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Chun Gui</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Chun Gui</span></h3>
<div class="p">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gui%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chun Gui</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Fei Liao</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Fei Liao</span></h3>
<div class="p">
<sup>4</sup>Department of Gastroenterology, Wuhan University Renmin Hospital, Wuhan, 430060 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fei Liao</span></a>
</div>
</div>
<sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Meixian Xiang</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Meixian Xiang</span></h3>
<div class="p">
<sup>5</sup>School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Meixian Xiang</span></a>
</div>
</div>
<sup>5,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Key Laboratory of Chinese Medicine Resources and Compound Formulas, Ministry of Education, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div id="Aff2">
<sup>2</sup>School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065 China </div>
<div id="Aff3">
<sup>3</sup>Hubei Shizhen Laboratory, Wuhan, 430061 China </div>
<div id="Aff4">
<sup>4</sup>Department of Gastroenterology, Wuhan University Renmin Hospital, Wuhan, 430060 China </div>
<div id="Aff5">
<sup>5</sup>School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, 430074 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 29; Accepted 2025 Aug 11; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370617  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40839202/" class="usa-link">40839202</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Modern pharmacology has found that both Realgar and <em>Coptis chinensis</em> can induce apoptosis in tumor cells, and traditional Chinese medicine theory suggests the possibility of combining the two, however, the specific mechanisms involved have not been elucidated. This study investigated the therapeutic mechanism of the Realgar-Coptis chinensis drug pair (RCCD) against hepatocellular carcinoma (HCC) by identifying its key active compounds and targets. Through integrated LC–MS analysis, transcriptomics, network pharmacology, and bioinformatics, we identified the mechanism of action, key bioactive compounds, and core targets. Molecular docking, molecular dynamics simulations, and microscale thermophoresis (MST) validated the binding affinity between key compounds and core targets. TIMER2.0 database was used to analyze the relationship between the core targets and HCC. H22 tumor xenograft mouse model and immunohistochemistry and pathology analyses were performed to validate the antitumor efficacy of the active compounds. RCCD has a high degree of selectivity of lipid metabolism pathway, 4-Methylumbelliferone (4-MU) was the key active compound with strong binding activity to the core target fatty acid synthase (FAS), and 4-MU down-regulated the expression of FASN in tumor tissues and induced apoptosis in HCC cells. In addition, as a hyaluronan synthase (HAS2/3) inhibitor, 4-MU interfered with the HA-dependent tumor microenvironment and fibrosis process by inhibiting HAS2/3. Thus, 4-MU may inhibit tumor progression by inhibiting FAS and HAS2/3. 4-MU extracted from RCCD exerts anti-HCC effects by modulating the activities of FAS and HAS2/3, thereby reprogramming lipid metabolism and regulating hyaluronan synthesis.</p>
<section id="sec1"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/b68cd5e7d0be/13659_2025_540_Figa_HTML.jpg" loading="lazy" id="MO1" height="441" width="784" alt="graphic file with name 13659_2025_540_Figa_HTML.jpg"></a></p></section><section id="sec2"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s13659-025-00540-9.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> 4-MU, Liver cancer, Cancer, Lipid metabolism, MST</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Globally, liver malignancies rank sixth in cancer incidence and third in cancer-related mortality [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The insidious onset of HCC often results in late-stage diagnoses, precluding curative surgery [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Patients thus rely on suboptimal therapies such as chemotherapy, targeted agents, and immunotherapies, which exhibit significant toxicity profiles. Targeting lipid metabolic pathways represents a promising therapeutic strategy, given their central role in HCC progression and metastasis [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Lipid metabolism sustains tumorigenesis by regulating cellular growth, energy homeostasis, and signaling cascades. Tumor cells exploit upregulated fatty acid synthesis, catabolism, and biomolecule production to fuel proliferation, invasion, metastatic dissemination, and therapy resistance [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Cellular homeostasis is intrinsically linked to lipid metabolic regulation [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. During tumor progression, nutrient-deprived microenvironments drive cancer cells to depend on lipid metabolism for rapid biomass expansion, survival, and metastatic competence [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p>
<p id="Par4">Modern pharmacological studies have established that Realgar and <em>Coptis chinensis</em> induce tumor cell apoptosis [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. traditional Chinese medicine classifies Realgar as a thermogenic and hepatotoxic agent linked to the liver meridian, while <em>Coptis chinensis</em> is categorized as a cold-natured, bitter herb acting on the heart and stomach meridians [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. As a thermogenic agent, Realgar neutralizes hepatotoxins, whereas the cold nature of <em>Coptis chinensis</em> exerts antipyretic effects. The synergy between these two agents balances their thermogenic and cold properties, amplifying detoxification efficacy. However, the therapeutic mechanisms of this drug pair in oncology remain incompletely characterized, necessitating systematic exploration.</p>
<p id="Par5">Studies show that tumor cells often face harsh conditions of low oxygen and nutrition due to connective tissue formation, defective vasculature, and rapid proliferation. Thus, tumor cells adapt metabolically, with lipid metabolism reprogramming being a key part. In normal cells, lipid synthesis is regulated by negative feedback [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. When intracellular lipid concentration reaches a certain level, synthesis stops to prevent resource waste [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. In tumor cells, the regulatory mechanism of lipid synthesis fails. Even with normal intracellular lipid levels, lipid metabolism remains highly active, constantly supplying material and energy for rapid proliferation [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. In normal cells, lipid metabolic pathways maintain basic functions like cell membrane structure, energy storage, and signal transduction [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. In contrast, tumor cells increase fatty acid utilization through overexpression of fatty acid metabolizing enzymes, supporting their growth, invasion, and metastasis [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. In normal cells, metabolic enzymes perform traditional functions such as gluconeogenesis and lipid synthesis. However, in tumor cells, metabolic enzymes may acquire new, non-classical functions. These differences in lipid metabolism between HCC and normal cells make inhibiting lipid metabolism a safe and effective strategy for treating HCC [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. In addition, HAS2/3 provides a favorable microenvironment for tumor cells by promoting their growth and metastasis through increased HA synthesis, and its activity is closely related to the extracellular matrix (ECM) in the tumor microenvironment [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. As an important component of the ECM, HA regulates cell adhesion, migration, and signaling by binding to cell surface receptors such as CD44 [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par6">Preliminary transcriptomic analyses demonstrated that the RCCD suppresses HCC through lipid metabolic modulation. Lipid metabolism sustains cellular homeostasis by coordinating fatty acid transport, biosynthesis, storage, and β-oxidation. FAS, a master regulator of lipid metabolism, drives cancer cell proliferation and survival [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Hypoxia-inducible factors activate FASN transcription under low oxygen tension, sustaining energy metabolism and membrane integrity in cancer cells [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. As the sole enzyme catalyzing palmitate synthesis from carbohydrate precursors, FAS generates essential substrates for long-chain and polyunsaturated fatty acid production [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Current FAS inhibitor development prioritizes clinical-stage agents like TVB-2640 (targeting solid tumors including glioblastoma, breast, lung, and colorectal carcinomas), whereas preclinical candidates such as cerulenin and C75 remain under investigation [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. FAS inhibitors exhibit broad-spectrum antitumor efficacy across diverse malignancies [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>].</p>
<p id="Par7">Transcriptomics involves the examination of RNA to understand gene expression, focusing on the transcriptional activity and the modulation of the transcriptome at either the cellular or tissue level [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. The transcriptome includes all RNA molecules transcribed in living cells and is a crucial tool for exploring cellular features and functions. The process of transcription, which involves the use of a DNA template to produce RNA, marks the commencement of gene expression and serves as a pivotal juncture in the regulation of genetic activity [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Transcriptomics facilitates the quantification of gene expression across the entire genome within cellular or tissue samples, thereby enabling the assessment of alterations within living organisms under defined experimental settings.</p>
<p id="Par8">MST is a flexible and potent method for probing the dynamics of biomolecular interactions. It accomplishes this by quantifying the migration of molecules in response to a thermal gradient. This motion, known as thermophoresis, is influenced by changes in hydration shell, charge, or molecular size [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. MST uses fine capillaries and infrared lasers to create microscopic temperature gradients. The target molecule’s fluorescence changes in response to this gradient, allowing detection of binding events. This technique’s advantage is that it does not require immobilizing the molecule on a surface, allowing measurements in the molecule’s native state. MST is highly sensitive and can detect subtle changes like protein phosphorylation events or small molecule binding [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. It is suitable for various applications, including analyzing interactions between proteins, DNA, RNA, peptides, small molecules, and ions. Additionally, MST can be used in various buffer conditions and with different sample types, including liposomes, vesicles, and nanoparticles. MST data are plotted against ligand concentration to generate dose–response curves, allowing binding affinities to be inferred. This provides accurate and reliable data on the binding affinity and kinetics of biomolecular interactions [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<p id="Par9">In this study, based on transcriptomic results, the active ingredients of RCCD and their targets were screened by network pharmacology and bioinformatics. The interaction of 4-MU with FAS was verified by MST [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. The antitumor activity of 4-MU and its effects on lipid metabolic pathways were investigated using the H22 mouse tumor model. The inhibitory effect of 4-MU on HAS2/3, combined with its antitumor activity and effects on lipid metabolic pathways, provides a new potential direction for the treatment of HCC and the development of novel tumor therapeutic strategies.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Qualitative analysis</h3>
<p id="Par10">After appropriate chromatographic pretreatment, samples were analyzedby LC–MS. By comparing relative retention time, UV absorption spectra, and the published literature [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>], mass spectrometry fragmentation of the chromatographic peaks indicated that Epiberberine, 4-MU, Jatrorrhizine, and other compounds acted as binding ligands (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/658f71331a96/13659_2025_540_Fig1_HTML.jpg" loading="lazy" id="MO2" height="797" width="797" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Analysis of active components in RCCD by LC–MS. Liquid chromatogram: The chromatographic peak of the standard of the sample. Peak <strong>a</strong>: Jatrorrhizine; Peak <strong>b</strong>: columbamine; Peak <strong>c</strong>: Epiberberine; Peak <strong>d</strong>: 4-MU; Peak <strong>e</strong>: Coptisine; Peak <strong>f</strong>: palmatine; Peak <strong>g</strong>: Berberine; Peak <strong>h</strong>: Oxyepiberberine</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Identification of differentially expressed genes</h3>
<p id="Par11">Differential genes were identified using DEG-seq software, with statistical significance defined as Log2FC(H_O/H) ≥ 2 and P &lt; 0.05. A total of 45 differentially expressed genes highly (Supplementary Table S1). These genes exhibited high correlation with lipid metabolism, and the lipid metabolism pathway was identified as the core pathway for drug interference with tumor cell development (Fig. <a href="#Fig2" class="usa-link">2</a>A). which illustrates the correlation between these 45 differentially expressed genes and lipid metabolism in liver cancer (LIHC) [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>].</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/751f4c9cf458/13659_2025_540_Fig2_HTML.jpg" loading="lazy" id="MO3" height="803" width="783" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Association of 45 cancer-related differential genes with HCC and lipid metabolism. <strong>A</strong> Correlation between differentially expressed genes and lipid metabolism in HCC from transcriptome data. <strong>B</strong> Differentially expressed genes and HCC, LIHC, and the intersection between lipid metabolism. <strong>C</strong> Top 10 enriched GO terms (BP, CC, MF) for the 42 differentially expressed genes</p></figcaption></figure><p id="Par12">Of the 45 differentially expressed genes, 30 were associated with lipid metabolism in HCC, of which the five genes with the highest correlation were H19, FASN, NOTCH2, ZFAS1 and CDH2. 24 were associated with lipid metabolism, of which the five genes with the highest correlation were FASN, H19, SP100, DSP and VCL. 41 were associated with HCC. The five genes with the highest correlation were H19, ZFAS1, NOTCH2, FASN and SNHG3. Notably, FASN showed significant correlation in all three domains (Fig. <a href="#Fig2" class="usa-link">2</a>B). After excluding three unrelated genes, the remaining 42 differentially expressed genes were analyzed for Gene Ontology (GO) enrichment (Fig. <a href="#Fig3" class="usa-link">3</a>C). The top 10 pathways including biological processes (BP), cellular components (CC), and molecular functions (MF) were illustrated using bar graphs. The most prominent pathway enriched for BP was mitochondrial RNA processing, the most prominent pathway enriched for CC was fascial adhesion, and the most prominent pathway enriched for MF was RNA binding.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/18937c063ea4/13659_2025_540_Fig3_HTML.jpg" loading="lazy" id="MO4" height="501" width="784" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Intersection target enrichment results. <strong>A</strong> Bubble chart of KEGG pathway. <strong>B</strong> Bubble chart of BP. <strong>C</strong> Bubble chart of CC. <strong>D</strong> Bubble chart of MF</p></figcaption></figure></section><section id="Sec5"><h3 class="pmc_sec_title">Prediction and analysis of the target genes</h3>
<p id="Par13">Twenty active ingredients were identified based on the results of LC/MS and traditional Chinese medicine databases, as well as relevant literature. Subsequently, the differentially expressed genes were integrated with the target genes of these 20 active compounds, yielding a total of 899 target genes. A total of 611 lipid metabolism target genes were identified and screened from GeneCards. Venn analysis was employed to compare the target genes of the active compounds with those associated with the disease, identifying 101 overlapping target genes (Supplementary Table S2). These intersecting targets were subsequently uploaded to the DAVID database for further analysis. The top 15 pathways, including BP, CC, and MF, were graphically represented using bubble charts (Figs. <a href="#Fig3" class="usa-link">3</a>A–D).</p>
<p id="Par14">The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that all 101 potential target genes were significantly enriched across 158 pathways (Fig. <a href="#Fig3" class="usa-link">3</a>A). Notably, 153 of these pathways showed a significant association with the target genes at a P-value of 0.05 or less. The most prominently represented pathways were Metabolic pathways (26.73%), Pathways in cancer (25.74%), and Chemical carcinogenesis—receptor activation (22.77%).</p>
<p id="Par15">GO enrichment analysis revealed that all 101 genes (100%) were associated with BP, CC, and MF. Specifically, BP enrichment was mainly associated with: positive regulation of transcription by RNA polymerase II (33.66%), positive regulation of DNA-induced transcription (24.75%), negative regulation of transcription by RNA polymerase II (17.82%), and signal transduction (17.82%) (Fig. <a href="#Fig3" class="usa-link">3</a>B). CC enrichment was mainly associated with: cell membrane (52.48%), cytoplasm (51.49%), nucleus (50.49%), and nucleolus (41.58%) (Fig. <a href="#Fig3" class="usa-link">3</a>C). MF enrichment was mainly associated with: protein binding (79.21%), isoform protein binding (30.69%), zinc ion binding (21.78%), and nuclear receptor activity (18.81%) (Fig. <a href="#Fig3" class="usa-link">3</a>D). KEGG and GO enrichment analysis of overlapping targets may provide valuable information for understanding the antitumor and anti-HCC properties of RCCD.</p>
<p id="Par16">The bioconcentration data indicate that the mechanism of action of RCCD involves the binding to specific proteins, thereby modulating their functions, regulating associated metabolic pathways, and influencing DNA expression to ultimately affect protein synthesis.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Network construction</h3>
<p id="Par17">Targets enriched in the top KEGG pathway, Metabolic pathways, and 20 active compounds were imported into Cytoscape 3.10.1 to construct a “core pathway-compound-target” network for core signaling pathways (Fig. <a href="#Fig4" class="usa-link">4</a>A). The network diagram illustrated the combined impact of various compounds on multiple targets within key signaling pathways when the RCCD was used to modulate lipid metabolism. By examining the degree values within this network, it was possible to pinpoint high-degree nodes that could represent potential active compounds (Table <a href="#Tab1" class="usa-link">1</a>). This approach suggests that the compounds associated with the highest degree values may have a significant influence on the network, indicating that they could be crucial in the therapeutic effects of the drug pair on lipid metabolism. These high-degree nodes are likely interacting with multiple targets, which may contribute to the overall synergistic effect observed in the treatment. It can be considered that when the RCCD exerts anti-cancer effects through lipid metabolism, high-degree compounds play a crucial role in the core pathways.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/063339cbb99d/13659_2025_540_Fig4_HTML.jpg" loading="lazy" id="MO5" height="1180" width="674" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>network analysis. <strong>A</strong> “core pathway-compound-target” network. <strong>B</strong> “PPI” network</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>The top 8 active compounds and potential targets</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Compound</th>
<th align="left" colspan="1" rowspan="1">Degree</th>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Degree</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Epiberberine</td>
<td align="center" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1">FASN</td>
<td align="center" colspan="1" rowspan="1">15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4-MU</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">PTGS2</td>
<td align="center" colspan="1" rowspan="1">14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Quercetin</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">SIRT1</td>
<td align="center" colspan="1" rowspan="1">12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Palmatine</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">CYP19A1</td>
<td align="center" colspan="1" rowspan="1">10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">(R)-Canadine</td>
<td align="center" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">CYP2C9</td>
<td align="center" colspan="1" rowspan="1">9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Worenine</td>
<td align="center" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">G6PD</td>
<td align="center" colspan="1" rowspan="1">9</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par18">After the identification and concentration of key elements within the central pathways, these elements were subsequently uploaded to the STRING platform for further analysis. Subsequently, a Protein–Protein Interaction (PPI) network was meticulously constructed using the software Cytoscape 3.8.2 (Fig. <a href="#Fig4" class="usa-link">4</a>B). This PPI network provides a visual representation of the interactions between proteins, which is instrumental in understanding the complex BP at play. The network can help identify key proteins that may be central to the pathways targeted by the RCCD, offering further insights into their potential synergistic effects on lipid metabolism. Core targets were identified by analyzing the degree values of the network diagram (Table <a href="#Tab1" class="usa-link">1</a>). These targets play crucial roles in the core signaling pathways.</p>
<p id="Par19">Within the PPI network, FASN (degree = 15) emerged as the highest-connectivity core target. This pivotal enzyme orchestrates de novo lipogenesis in HCC, fueling pathogenic palmitate accumulation via the HBx-SREBP1c transcriptional axis to sustain tumor bioenergetics and membrane dynamics [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. PTGS2 (degree = 14) amplifies inflammatory cascades by converting FASN-derived arachidonic acid into protumorigenic prostaglandin E<sub>2</sub>, establishing a self-perpetuating lipid-inflammation feedforward loop that drives IL-6/STAT3-mediated malignant transformation in non-alcoholic steatohepatitis [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. SIRT1 (degree = 12) functions as a context-dependent metabolic rheostat, exhibiting stage-specific duality: during early hepatocarcinogenesis it activates AMPK to suppress SREBP1c/FASN-driven lipogenesis, whereas in advanced HCC it stabilizes HIF-1α through deacetylation to potentiate glycolytic flux and lipid droplet storage [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>, <a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>].</p>
<p id="Par20">The “active ingredient-target” network was utilized to identify Epiberberine, 4-MU, quercetin, and palmatine as the core active ingredients with the highest degree of activity (Table <a href="#Tab1" class="usa-link">1</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">FAS protein expression in HCC</h3>
<p id="Par21">The results of biosignature analysis demonstrate that FASN mRNA is significantly overexpressed in HCC tissues (Fig. <a href="#Fig5" class="usa-link">5</a>A), and its protein level is also significantly upregulated (Fig. <a href="#Fig5" class="usa-link">5</a>B). FAS protein expression was elevated approximately 2.5-fold in tumor tissues compared with normal liver tissues (p &lt; 0.001) (Fig. <a href="#Fig5" class="usa-link">5</a>C). Further analysis revealed that FASN expression was positively correlated with the pathological stage of HCC (F = 0.418, p = 0.74) (Fig. <a href="#Fig5" class="usa-link">5</a>D). Methylation analysis revealed that the methylation level of the FASN promoter region was negatively correlated with gene expression (r = − 0.21, p &lt; 0.05), suggesting that DNA methylation may regulate the aberrant expression of FASN (Fig. <a href="#Fig5" class="usa-link">5</a>E).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/d850ee069e9c/13659_2025_540_Fig5_HTML.jpg" loading="lazy" id="MO6" height="1240" width="773" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The expression of FASN in LIHC-Tumor. <strong>A</strong> FASN expression in LIHC-Tumor from TIMER2.0. <strong>B</strong> The protein levels of FAS in LIHC were analyzed using CPTAC. <strong>C</strong> Comparison of FASN expression differences between LIHC tumor tissues and normal tissues from TCGA database. <strong>D</strong> FASN expression levels and the pathological stages were analyzed using GEPIA2.0. <strong>E</strong> Correlation between methylation level and expression of FASN promoter</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">Binding of 4-MU to FAS and its effect on HepG2 cells</h3>
<p id="Par22">Molecular docking was performed using AutoDock, and the results were evaluated based on the free energy of binding. The free energy of binding, typically expressed in kcal/mol, represents the energy released when a ligand binds to a receptor. Binding free energies below − 1.2 kcal/mol are generally considered indicative of effective binding. The top four active ingredients and FAS were selected for docking. among all the active ingredients bound to FAS, 4-MU exhibited the lowest binding free energy (− 6.91 kcal/mol), indicating a more stable binding interaction (Table <a href="#Tab2" class="usa-link">2</a>). This suggests that 4-MU is the most likely core active ingredient to bind to and function with FAS (Fig. <a href="#Fig6" class="usa-link">6</a>A).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Dock binding free energies (△Gb) and bonds of the docked inhibitors against FAS</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">PDB code</th>
<th align="left" rowspan="2" colspan="1">Inhibitors</th>
<th align="left" rowspan="2" colspan="1">Gb (kcal/mol)</th>
<th align="left" colspan="3" rowspan="1">Bonds between groups of compounds and amino acids of FAS</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Groups of comp</th>
<th align="left" colspan="1" rowspan="1">Amino acid</th>
<th align="left" colspan="1" rowspan="1">Bonds name</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="18" colspan="1">8g7x</td>
<td align="left" rowspan="8" colspan="1">4-MU</td>
<td align="center" rowspan="8" colspan="1">− 6.91</td>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">ASN1025</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">LYS1023</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">PRO1003</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">PHE1029</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Six-member</td>
<td align="left" colspan="1" rowspan="1">SER1028</td>
<td align="left" colspan="1" rowspan="1">Pi-Pi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Six-member</td>
<td align="left" colspan="1" rowspan="1">PHE1029</td>
<td align="left" colspan="1" rowspan="1">Hydrophobic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ring Benzene</td>
<td align="left" colspan="1" rowspan="1">LYS1023</td>
<td align="left" colspan="1" rowspan="1">Hydrophobic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">THR1023</td>
<td align="left" colspan="1" rowspan="1">Hydrophobic</td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">Epiberberine</td>
<td align="center" rowspan="4" colspan="1">− 6.51</td>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">ASP962</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">ARG942</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">LEU938</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">ALA944</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">Palmatine</td>
<td align="center" rowspan="4" colspan="1">− 6.12</td>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">THR1087</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">LEU1097</td>
<td align="left" colspan="1" rowspan="1">C-H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">SER1037</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">O</td>
<td align="left" colspan="1" rowspan="1">ARG1082</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Quercetin</td>
<td align="center" rowspan="2" colspan="1">− 5.84</td>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">ALA943</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">ASP962</td>
<td align="left" colspan="1" rowspan="1">H-bond</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/e87d3ae2ade3/13659_2025_540_Fig6_HTML.jpg" loading="lazy" id="MO7" height="991" width="778" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>interaction of 4-MU with FAS and Results of HepG2 cell experiments. <strong>A</strong> Docking results of 4-MU with FAS. <strong>B</strong> RMSD of 4-MU and FAS complexes. <strong>C</strong> Energy of 4-MU and FAS complexes. <strong>D</strong> RMSF of 4-MU and FAS complexes. <strong>E</strong> Results of HepG2 cell experiments, IC50 = 85.4 μM, 95% confidence interval of 80.2–90.6 μM. <strong>F</strong>, <strong>G</strong> Molecular interactions of 4-MU by NT. 115 analysis. FAS (0.338 μM), 4-MU ranged from 3.38 mM to 5.15E-05 mM, Kd = 38.755 nM</p></figcaption></figure><p id="Par23">Root mean square deviation (RMSD) analysis quantified structural deviations from the initial conformation during simulation. The trajectory exhibited minor fluctuations but maintained overall stability with minimal backbone conformational changes (Fig. <a href="#Fig6" class="usa-link">6</a>B). Energy fluctuation analysis revealed initial high energy (19.054 kcal/mol) that gradually decreased and stabilized, indicating system convergence to a low-energy equilibrium state (Fig. <a href="#Fig6" class="usa-link">6</a>C). Root mean square fluctuation (RMSF) analysis assessed residue-specific flexibility, showing significant variation across protein regions that highlighted differential mobility during simulation (Fig. <a href="#Fig6" class="usa-link">6</a>D). Overall, the binding of 4-MU to FAS was stable, and the complex maintained a consistent conformation and lower energy state throughout the simulation. The ADME properties of 4-MU (Table <a href="#Tab3" class="usa-link">3</a>), indicate favorable intestinal absorption, high water solubility, and good drug-forming properties.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>ADME properties of 4-MU</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Lipophilicity</th>
<th align="left" colspan="1" rowspan="1">Water solubility</th>
<th align="left" colspan="1" rowspan="1">Pharmacokinetics</th>
<th align="left" colspan="1" rowspan="1">Druglikeness</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">Consensus Log <em>P</em><sub><em>o/w</em></sub> = 1.81</td>
<td align="left" colspan="1" rowspan="1">log S (ESOL) = − 2.70</td>
<td align="left" colspan="1" rowspan="1">GI absorption: High</td>
<td align="left" colspan="1" rowspan="1">Lipinski: Yes; 0 violation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Class (ESOL): Soluble</td>
<td align="left" colspan="1" rowspan="1">BBB permeant: Yes</td>
<td align="left" colspan="1" rowspan="1">Bioavailability Score = 0.55</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par24">A dose-dependent effect of 4-MU on HepG2 cell viability was observed. The IC50 value of 4-MU for HepG2 cells was 85.4 μM, with a 95% confidence interval of 80.2–90.6 μM. This indicates that 4-MU can produce significant inhibitory effects on HepG2 cells at moderate concentrations (Fig. <a href="#Fig6" class="usa-link">6</a>E).</p>
<p id="Par25">The interaction between 4-MU and FAS was evaluated using MST, a technique that quantifies molecular affinity. The dissociation constant (Kd) was determined by assessing the normalized fluorescence intensity variance between the ligand-receptor binding complex and the unbound ligand, which allowed for the subsequent calculation of the binding fraction.</p>
<p id="Par26">In the process, a range of concentrations of the active compound was introduced to the target protein, and the MST instrument monitored the fluorescence signal change as the molecules experienced thermal motion within a temperature gradient. This change in fluorescence signal was amplified by a factor of 1000 and expressed as relative fluorescence units. Following that, the Kd was determined from the standardized variation in fluorescence signal, comparing the states where the ligand was bound versus unbound to the protein. The findings indicated a robust binding affinity of 4-MU for the target protein FAS, as detected by MST (Figs. <a href="#Fig6" class="usa-link">6</a>F and G).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Results of in vivo anti-tumor assay</h3>
<p id="Par27">The antitumor efficacy of 4-MU was evaluated in BALB/c mice bearing H22 tumor xenografts. After tumor implantation, mice were weighed every two days, and tumor size was measured using digital calipers to calculate tumor volume (Figs. <a href="#Fig7" class="usa-link">7</a>A and 7B). After 14 days, mice were euthanized, and blood was collected for lipid content analysis (Fig. <a href="#Fig7" class="usa-link">7</a>C). Tumor tissues were excised from the mice for histopathological sectioning (Fig. <a href="#Fig7" class="usa-link">7</a>D). Immunohistochemical analyses of tumor tissues were conducted (Figs. <a href="#Fig8" class="usa-link">8</a>A, B, and C).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/4fac085010c5/13659_2025_540_Fig7_HTML.jpg" loading="lazy" id="MO8" height="344" width="784" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of 4-MU on mouse xenograft models and tumor tissues. <strong>A</strong> Tumor volume. <strong>B</strong> Body weight. <strong>C</strong> Lipid Changes. <strong>D</strong> HE image of tumor tissue (original magnification 400 ×)</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370617_13659_2025_540_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fea/12370617/be054d28489a/13659_2025_540_Fig8_HTML.jpg" loading="lazy" id="MO9" height="466" width="784" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effect of 4-MU on protein expression in tumor tissues of a mouse xenograft model. <strong>A</strong> ICH image of FAS (original magnification 400 ×). <strong>B</strong> ICH image of Bax (original magnification 400 ×). <strong>C</strong> ICH image of Bcl-2 (original magnification 400 ×)</p></figcaption></figure><p id="Par28">The dose-dependent effects of 4-MU on tumor progression and body weight changes in tumor-bearing mice were assessed. By day 10, tumor growth in the control group showed a marked acceleration (P &lt; 0.05 compared to baseline). Conversely, 4-MU treatment resulted in dose-dependent tumor suppression, with significant growth inhibition observed at all tested concentrations (P &lt; 0.01 vs. control) (Figs. <a href="#Fig7" class="usa-link">7</a>A and B). The dose-responsive alterations in serum lipid profiles following 4-MU administration were observed. Dose-dependent reductions were observed in TC, TG, and LDL-C levels, whereas HDL-C concentrations showed a progressive increase across treatment groups. These lipid-modulating effects were mediated through 4-MU's inhibition of FAS activity, which subsequently attenuated fatty acid biosynthesis and regulated cholesterol homeostasis (Fig. <a href="#Fig7" class="usa-link">7</a>C).</p>
<p id="Par29">The effects of 4-MU on mouse tumor cells were observed. In tumor tissues, cell density decreased with increasing drug dose; cell arrangement became more disorganized; and tissue necrosis or abnormal cell proliferation was observed, with nuclei stained dark purple and cytoplasm stained pink (Fig. <a href="#Fig7" class="usa-link">7</a>D).</p>
<p id="Par30">4-MU treatment induced a concentration-dependent suppression of FAS protein expression, as visualized by diminished yellow–brown immunohistochemical staining intensity (Fig. <a href="#Fig8" class="usa-link">8</a>A). Consistent with its role in apoptosis modulation, 4-MU significantly altered critical regulators of cell death in H22 tumor-bearing mice: Bax expression progressively intensified with escalating drug concentrations (Fig. <a href="#Fig8" class="usa-link">8</a>B), whereas Bcl-2 expression exhibited reciprocal attenuation (Fig. <a href="#Fig8" class="usa-link">8</a>C). This concerted dysregulation culminated in a dose-responsive decline of the Bcl-2/Bax ratio, functionally demonstrating enhanced tumor cell apoptosis through mitochondrial pathway activation.</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par31">Modern studies have found that Realgar and <em>Coptis chinensis</em> are cytotoxic, inducing tumor cell death and inhibiting tumor growth and survival [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>–<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Active lipid metabolism in HCC cells supports their rapid survival and proliferation in the harsh microenvironment, playing a crucial role in tumor development [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Based on LC/MS and transcriptomics data, the “Core Pathway-Compound-Target” network and the PPI network were established using a network pharmacology approach. This study investigated the active ingredients, potential target genes, and related signaling pathways of RCCD in anti-HCC, focusing on lipid metabolism to elucidate its possible mechanism of action. Then, the network pharmacology results were validated through MST experiments, as well as in vitro and in vivo studies.</p>
<p id="Par32">Through data screening and analysis, 20 active compounds, core signaling pathways, and 27 potential target genes related to the core pathways were identified. These may represent the mechanisms by which the RCCD intervenes in lipid metabolism. GO functional and KEGG pathway enrichment analyses identified 101 overlapping target genes that are implicated in various cellular compartments, including the cytosol, cytoplasm, and nucleus. Molecularly, these overlapping targets were engaged in processes such as protein binding, homotypic protein binding, and nuclear receptor activity. They pertained to the facilitation of transcription by RNA polymerase II, the enhancement of DNA-templated transcription, and the suppression of transcription by RNA polymerase II. The results suggest that 4-MU may inhibit tumor cell proliferation and promote tumor cell death by binding to proteins in the cytoplasm and affecting the expression of lipid metabolism-related genes. 4-MU may exert its anti-leukemia effects by inhibiting key targets of lipid metabolism. Analysis of the PPI network and the “core pathway-compound-target” network, as well as molecular docking, identified 4-MU as a potential active compound and FASN as a potential target gene related to lipid metabolism.</p>
<p id="Par33">FAS, a pivotal enzyme in the de novo synthesis of fatty acids, exerts a critical rate-limiting influence on the intracellular fatty acid synthesis pathway. It is essential for maintaining the energy metabolism and structural homeostasis of cancer cell membranes [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. FAS is the only enzyme capable of converting carbohydrate metabolites into palmitate, a key component of long-chain and polyunsaturated fatty acids. Fatty acids are vital components of cell membranes, and FAS maintains their integrity and function by synthesizing fatty acids. In various malignancies, including breast, prostate, and lung cancer, FAS expression is notably increased. Given that tumor cells demand substantial fatty acid supplies to fuel their accelerated growth and proliferation, FAS inhibition emerges as a promising therapeutic strategy against cancer [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p>
<p id="Par34">The Bcl-2 family can be categorized into two subgroups: proteins that oppose apoptosis and those that promote it. Bcl-2 and Bax are considered the key representatives of the anti-apoptotic and pro-apoptotic factions, respectively. In most tumors, Bcl-2 expression is elevated, while Bax expression is reduced. Reducing Bcl-2 levels or increasing Bax levels can stimulate the process of apoptosis in a variety of cancer cells. The balance between Bax and Bcl-2 expression is significantly associated with the growth and advancement of tumors [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>].</p>
<p id="Par35">MST assays reveal a strong binding interaction between 4-MU and FAS. Molecular docking and MD simulations indicate that the 4-MU-FAS complex exhibits high stability. In vivo studies assessing the antitumor efficacy of 4-MU revealed that changes in mouse body weight indicated no significant adverse effects on overall health. The dose-dependent reduction of total blood cholesterol in mice demonstrated the inhibitory effect of 4-MU on lipid metabolism pathways. Since the synthesis of triglycerides and LDL cholesterol depends on fatty acids, as the dose of 4-MU increases, triglycerides and LDL cholesterol decrease, while HDL cholesterol increases. Therefore, as the dose of 4-MU increased, triglycerides and LDL cholesterol decreased, while HDL cholesterol increased, likely due to rebalancing of cholesterol metabolism from FAS inhibition. Tumor suppression rates and histological findings indicate that 4-MU inhibits tumor proliferation with mild efficacy at low doses and significant efficacy at high doses.In vivo studies have shown that moderate to high concentrations of 4-MU can inhibit tumor expansion, suppress lipid metabolism activity, improve the health status of tumor-bearing mice, and alter the cellular appearance and structure of tumors. By binding to FAS protein, 4-MU severely disrupts lipid metabolism. This action causes an energy metabolism crisis and imbalances cell membrane structure in tumor cells. Additionally, the accumulation of acetyl-coenzyme A, a precursor for fatty acid synthesis, activates acetylation modification, which induces tumor cells to enter the pro-apoptotic signaling pathway, ultimately leading to apoptosis. In conjunction with network pharmacology results, 4-MU was found to inhibit FAS activity. This inhibition disrupts the cell membrane and subsequent fatty acid-based energy supply of tumor tissues, thereby inhibiting tumor growth and inducing apoptosis [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<p id="Par36">Notably, 4-MU was reported as a hyaluronic acid synthase inhibitor in previous studies, which significantly reduced the synthesis of hyaluronic acid (HA) in the ECM by inhibiting the expression of HAS2/3, thereby interfering with HA-dependent tumor microenvironment construction and fibrosis progression [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>–<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Combined with its inhibitory effect on FAS, this multi-target property allows 4-MU to exhibit synergistic anti-tumor and anti-fibrosis effects independent of dietary regulation. The dual targeting of FAS and HAS2/3 by 4-MU elicits synergistic anti-tumor effects in HCC. This profound synergy originates from reciprocal reinforcement within a metabolic-ECM signaling loop: FAS-derived palmitoyl-CoA activates SREBP2-mediated HAS2 transcription while generating UDP-GlcNAc—the essential HA precursor. Reciprocally, HA-CD44 complexes facilitate lipid raft assembly that potentiates EGFR/IGF1R-PI3K/AKT signaling, driving SREBP1c phosphorylation to amplify FASN expression and lipogenesis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>, <a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. 4-MU dismantles this vicious cycle through dual mechanisms: depleting palmitoyl-CoA pools to disrupt SREBP2-HAS2 axis activation, and directly suppressing HA synthesis. This coordinated action collapses CD44-EGFR signalosomes and abrogates AKT-dependent SREBP1c maturation, inducing metabolic catastrophe through simultaneous lipid substrate deprivation and survival signal ablation. The therapeutic intervention transcends additive effects by eroding HCC's adaptive infrastructure, achieving tumor regression through coordinated disruption of oncogenic metabolism and stromal protection. This "dual-hit" strategy concurrently inhibits malignant proliferation and stromal support, with preclinical evidence confirming enhanced therapeutic efficacy when targeting both metabolic and microenvironmental pathways in solid tumors [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>].</p>
<p id="Par37">However, 4-MU’s systemic effects may be accompanied by a risk of immunosuppression, and its poor water solubility limits clinical translation. In contrast, TVB-2640 is a highly selective direct inhibitor of FAS. TVB-2640 has been proved to significantly reduce liver fat content (ΔMRI-PDFF≈30%) and inhibit tumor growth in non-alcoholic steatohepatitis and solid tumors in phase II clinical trials, but its mechanism of action is simple and it lacks the ability to regulate ECM remodeling [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>, <a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. This mechanistic comparison suggests 4-MU's multitargeted profile offers superior therapeutic potential for complex pathologies like fibrotic tumor microenvironments, whereas TVB-2640's selectivity suits metabolic-disorder-driven malignancies.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par38">In summary, our study demonstrated that 4-MU, the active ingredient in RCCD, binds to the lipid metabolism-related target FAS, inhibiting fatty acid synthesis and disrupting the balance of cellular membrane structure and energy supply. This inhibition reduced tumor growth in a mouse xenograft model without significantly affecting the overall health of the mice. Moreover, due to its inhibitory effect on HAS2/3, 4-MU may be more advantageous in treating tumor-fibrosis co-morbidities than FAS inhibitors alone, such as TVB-2640. This finding provides a theoretical basis for developing anticancer drugs that target lipid metabolism.</p></section><section id="Sec12"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec13"><h3 class="pmc_sec_title">Chemical and reagents</h3>
<p id="Par39">4-MU (CAS 90-33-5), was sourced from Shanghai Yuanye Bio-Technology Co., Ltd. (China), and was provided with a purity of no less than 98%. The FAS (ab131929), Bcl-2 (ab182858) and Bax (ab81083) was procured from Abcam, located in Cambridge, UK.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Cell culture and binding component screening</h3>
<p id="Par40">HepG2 cells, sourced from the Cell Bank of the Chinese Academy of Sciences, were maintained in a cell incubator under a 5% CO<sub>2</sub> atmosphere at a temperature of 37 °C, utilizing a specialized HepG2 cell culture medium provided by Procell Life Science &amp; Technology Co., Ltd. Cells that had grown to confluence were transferred into 6-well plates. The control group was maintained in the standard culture medium, while the experimental group was treated with a medium containing a mixture of Realgar and <em>Coptis chinensis</em>, supplied by the Hubei Key Laboratory of Chinese Medicine Resources and Chemistry. A portion of the incubated and non-incubated cells was reserved for transcriptome sequencing analysis (Sect. <a href="#Sec16" class="usa-link">5.4</a>).</p>
<p id="Par41">Total proteins were ex-tracted from cells using RIPA buffer with protease/phosphatase in-hibitors (Beyotime Biotechnology, China). 0.11 g/mL methanol extract of the mixture (8.54 g of the mixture were obtained from the Key Laboratory for Traditional Chinese Medicine Resources and Chemistry of Hubei Province) was dissolved to 11 mg/mL by 0.5 M potassium Sephosphate buffer (pH 7); 12 μL of total protein, 60 μL of methanol Dextract and 168 μL of 0.5 M potassium phosphate buffer (pH 7) were stmixed and incubated at 37 °C for 60 min. After incubation, the mixture Qwass filtered for 30 min using an ultrafiltration centrifugal tube (Millipore) at 6350 g and 4 °C, and then washed twice with potassium phosphate buffer to remove unbound compounds. The protein complexwhich was retained on the membrane of the ultrafiltration device wasthen transferred to a new centrifuge tube.</p></section><section id="Sec15"><h3 class="pmc_sec_title">LC–MS analysis</h3>
<p id="Par42">The 0.22 pm filtration membrane was used to produce a stocksample solution which was analyzed by HPLC-DAD-ESI-MS. Chromatography was performed with a Hanbon LichrospherTM highperformance liquid chromatography C18 column (4.6–250 mm, 5 pm) at 25 C. The mobile phase consisted of solvent A (acetonitrile) and solvent B (0.03 mol/L ammonium bicarbonate aqueous solution). The gradient elution program was set as follows: 0–12 min, 10–25% A; 12–20 min, 25–27% A; 20–32 min, 27–45% A; 32–35 min, 45% A maintained. It's 10 μL permilliliter per minute. The detection wavelength is 190–690 nm. TheSettings of mass spectrometry are as follows; turbine spray temperature:550 °C, source voltage: 5.5 kv for positive ion mode and − 4.5 kv fornegative ion mode. M/Z varies from 50 to 1600. Compounds wereidentified by their precise mass, mass/mass ion fragment patterns andretention time in liquid chromatography.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Transcriptome sequencing analysis</h3>
<p id="Par43">Total RNA was extracted from both groups following the protocol of the TruSeq™ RNA Sample Preparation Kit from San Diego, CA. RNA samples of high integrity (5 μg, with an OD260/280 ratio of 1.8–2.2) were selected for the construction of sequencing libraries. mRNA with polyA tails was captured from eukaryotic mRNA using magnetic beads coated with Oligo (dT). The captured mRNA was then randomly fragmented into approximately 300 bp segments by the addition of a fragmentation buffer. Subsequently, single-stranded cDNA was synthesized using reverse transcriptase, resulting in a stable double-stranded structure.</p>
<p id="Par44">The adapter-ligated samples underwent purification and size selection, followed by PCR amplification to selectively enrich the desired products, resulting in the formation of the final library. Subsequently, these libraries were prepared for sequencing using the Illumina HiSeq Xten/Nova-Seq 6000 platform.</p>
<p id="Par45">Rotating Scanning Electron Microscopy was utilized to perform a quantitative assessment of the transcript and gene expression levels across various samples, highlighting disparities in expression profiles. A differential gene expression analysis was then carried out to pinpoint and filter out genes that exhibited significant changes in expression levels. Subsequently, an in-depth investigation was conducted to explore the specific roles and functions of these differentially expressed genes [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>].</p></section><section id="Sec17"><h3 class="pmc_sec_title">Cross-target gene prediction</h3>
<p id="Par46">The bioactive components of Realgar and <em>Coptis chinensis</em> were identified via the TCMSP database (<a href="https://old.tcmsp-e.com/tcmsp.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://old.tcmsp-e.com/tcmsp.php</a>) and combined with the results of LC–MS analysis. The targets of these bioactive ingredients were then identified using PubChem (<a href="https://pubchem.ncbi.nlm.nih.gov/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubchem.ncbi.nlm.nih.gov/</a>), SwissTargetPrediction (<a href="http://www.swisstargetprediction.ch/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.swisstargetprediction.ch/</a>), and the PharmMapper Server (<a href="http://PharmMapper.rcas.sinica.edu.tw/steppp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://PharmMapper.rcas.sinica.edu.tw/steppp</a>) the targets of these bioactive ingredients were then identified. Proteins related to lipid metabolism were pinpointed with the help of GeneCards (<a href="https://www.genecards.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.genecards.org/</a>). Subsequently, the intersecting targets were subjected to the DAVID database (<a href="https://david.ncifcrf.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://david.ncifcrf.gov/</a>) to perform GO functional categorization and KEGG pathway enrichment analysis.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Network construction</h3>
<p id="Par47">Based on KEGG enrichment results, pathways were ranked by enrichment values, core pathways were screened, and related targets were imported into STRING for analysis. A PPI network was constructed to identify core targets. Active compounds and core pathway enrichment targets were uploaded to Cytoscape 3.10.1 to construct a “core pathway-compound-target” network for core signaling pathways [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Active compounds and enriched targets were input as nodes, with edges representing connections between them. By analyzing the network diagram, highly targeted compounds were identified.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Integrated analysis of FAS expression and methylation in HCC using public databases</h3>
<p id="Par48">The analysis of the differential expression of FASN mRNA in LIHC tumors and normal tissues in the TCGA cohort was performed using TIMER2.0 [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. The expression of FAS protein in HCC was verified based on CPTAC database [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. The gene expression data of HCC tumor tissues (n = 371) and normal liver tissues (n = 50) were obtained by TCGA database, and the independent sample t-test was used to compare the differences of FAS between the two groups. The correlation between FASN expression and the pathological stage of HCC (stage I-IV) was analyzed with the help of GEPIA2.0 platform, and one-way analysis of variance (ANOVA) was used to assess the differences between groups. Methylation data of HCC samples were extracted using the UCSC Xena database to analyze the correlation between the methylation level (β-value) of FASN promoter region and gene expression, and Pearson correlation coefficients were calculated.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Binding of 4-MU to FAS and its effect on HepG2 cells</h3>
<p id="Par49">To explore the binding affinity between specific bioactive substances and their prospective targets, a computational docking process was undertaken employing AutoDockTools (version 1.5.7). The 3D chemical structures for these substances were procured from PubChem. Corresponding 3D target protein structures were sourced from the Protein Data Bank (<a href="http://www.rcsb.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.rcsb.org/</a>). The docking simulations calculated the compounds' binding free energy within the macromolecular environment. Typically, a binding energy threshold below − 1.2 kcal/mol is interpreted as a positive docking outcome, suggesting a strong likelihood of the small molecule ligand binding to the receptor.</p>
<p id="Par50">To validate the stability of the 4-MU-FAS docking complex, MD simulations were performed using YASARA Structure 10.3.16. The system was solvated in a TIP3P water box extending 10 Å from the protein surface, with counterions added to neutralize the charge. The AMBER14 force field was applied to describe atomic interactions. Energy minimization was conducted using the steepest descent algorithm (5000 steps) to eliminate steric clashes. Subsequently, the system underwent equilibration in two phases: (1) NVT ensemble (constant particle number, volume, and temperature) at 298 K for 100 ps using the Berendsen thermostat; (2) NPT ensemble (constant pressure at 1 bar) for 200 ps with the Martyna-Tobias-Klein barostat. Production MD simulations were then carried out for 50 ns with a 2-fs integration time step under periodic boundary conditions. Trajectories were saved every 10 ps for analysis [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>].</p>
<p id="Par51">RMSD and RMSF of the protein backbone and ligand heavy atoms were calculated to assess structural convergence (RMSD &lt; 2.0 Å) and identify dynamic binding interface residues. Binding free energy was quantified via the Molecular Mechanics/Poisson-Boltzmann Surface Area method, revealing dominant contributions from hydrophobic interactions.</p>
<p id="Par52">For ADME prediction, the SwissADME platform (<a href="http://www.swissadme.ch/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.swissadme.ch/</a>) was employed to evaluate 4-MU’s pharmacokinetic properties.</p>
<p id="Par53">MST was utilized to explore the complex protein interactions characterized by substantial network connections. Prior to the analysis with the instrument, a concentration gradient of FAS, which was labeled using the Monolith NTTM Protein Labeling Kit RED-NHS (Catalog Number: L001), was examined, starting from a concentration of 1.89 µM and decreasing.</p>
<p id="Par54">Molecular interaction assessments were performed using the Monolith NT 115 device and standard 4 µL glass capillaries, which were supplied by NanoTemper Technologies GmbH in Munich, Germany. The recorded fluorescence intensity from the MST experiment was employed to calculate the Kd by applying appropriate data fitting methods [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>].</p>
<p id="Par55">HepG2 cells, sourced from the Cell Bank of the Chinese Academy of Sciences, were maintained in a cell incubator under a 5% CO<sub>2</sub> atmosphere at a temperature of 37 °C, utilizing a specialized HepG2 cell culture medium provided by Procell Life Science &amp; Technology Co., Ltd. After 48 h of treatment with medium containing a mixture of 4-MU (0 μM, 25 μM, 50 μM, 75 μM, 100 μM), cell survival was assayed using the CCK-8 assay.</p></section><section id="Sec21"><h3 class="pmc_sec_title">In vivo anti-tumor efficacy of 4-MU</h3>
<p id="Par56">Adult male BALB/c mice, with a weight range of 18–22 g, were sourced from the Hubei Provincial Center for Disease Control and Prevention. They were accommodated in a Specific Pathogen Free environment, where temperature and humidity were meticulously regulated at 25 °C. The animals were provided with unlimited access to food and water for a week to allow them to adjust to their surroundings. The study was granted ethical approval by the Animal Ethics Committee of Hubei University, adhering to the guidelines set by the Animal Care and Use Committee of the Chinese Institute of Pharmaceutical Sciences.</p>
<p id="Par57">Under aseptic conditions, 0.2 mL of H22 tumor cell suspension (1 × 10<sup>6</sup> cells/mL) was injected into the abdominal cavity of healthy mice. After successful inoculation, the mice were monitored for abdominal tumor development. On the seventh day post-inoculation, ascites were extracted from mice with ascites tumor growth, resulting in abdominal enlargement without signs of ulceration. The ascites was centrifuged to isolate tumor cells, and the concentration was adjusted to 5 × 10<sup>5</sup> cells/mL with saline. 0.2 mL of the adjusted cell suspension was injected subcutaneously into the dorsal side of 40 healthy mice under aseptic conditions. The mice were randomly divided into four groups of 10 mice each. The model group (given saline) was injected once a day, while the 4-MU treatment groups (25 mg/kg, 50 mg/kg, 100 mg/kg) were injected once a day for 14 days. Total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol were measured. Protein expression was determined by immunohistochemistry, and changes in tissue structure and cell morphology were observed by pathological sectioning.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par58">The collected experimental data were subjected to analysis using SPSS 16.0, an integrated statistical software suite, in conjunction with ImageJ, a dedicated image analysis software. The outcomes were reported as mean values complemented by their standard deviations. For evaluating the statistical significance of differences between groups, a ANOVA test was utilized. A threshold of p-value less than 0.05 was established to indicate a statistically significant disparity among the groups.</p></section></section><section id="Sec23"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12370617/bin/13659_2025_540_MOESM1_ESM.csv" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (96.1KB, csv) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12370617/bin/13659_2025_540_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2.</a><sup> (57.4KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We are deeply grateful for the funding support from the Natural Science Foundation of Hubei Province (NO.2024AFD252); Natural Science Foundation Project of Hubei Provincial Administration of Traditional Chinese Medicine (ZY2025D020); Fundamental Research Funds for the Central Universities South-Central MinZu University [NO. CZZ24017]; State Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project of Traditional Chinese Medicine—Chinese Medicine Resource Science (Medicinal Mineralogy); Open Fund of Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine and Hubei Provincial Department of Education Guiding Program (B2023089).</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Songtao Wu, Yingying Wang and Denghui Deng designed the study. Meixian Xiang, Chun Gui, Fei Liao, and Guohua Zheng organized the research consortium. Songtao Wu, Meixian Xiang, Denghui Deng and Chun Gui performed the fermentation, compound purification, and structural elucidation. Songtao Wu sequenced and assembled the genomic data and revised the manuscript. Hanxiang Mei and Cong Wang analyzed the biological data. Yingying Wang, Hanxiang Mei and Fei Liao performed the in vivo experiments using the H22 tumor xenograft mouse model. Songtao Wu and Chun Gui conducted the immunohistochemistry and pathology analyses. Denghui Deng and Xiang Zheng performed the molecular docking and MD simulations. Meixian Xiang conducted the MST experiments. Denghui Deng performed the network pharmacology analysis. Denghui Deng, Hanxiang Mei, Cong Wang, and Xiang Zheng drafted the manuscript. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by Natural Science Foundation of Hubei Province (2024AFD252); Natural Science Foundation Project of Hubei Provincial Administration of Traditional Chinese Medicine (ZY2025D020); Fundamental Research Funds for the Central Universities, South-Central Minzu University (<a href="https://www.ncbi.nlm.nih.gov/protein/CZZ24017" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CZZ24017</a>); State Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project of Traditional Chinese Medicine—Chinese Medicine Resource Science (Medicinal Mineralogy); Open Fund of Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine and Hubei Provincial Department of Education Guiding Program (B2023089).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data will be made available on request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par59">This experimental design was conducted and approved following the instructions of the institutional animal care and use committee of Ahram Canadian University (Approval number: REC2524). All animal experiments were conducted following the regulations of Directive 2010/63/EU in Europe, and this study is reported under ARRIVE guidelines (<a href="https://arriveguidelines.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://arriveguidelines.org</a>).</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par60">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par61">All authors declare no competing financial interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Songtao Wu, Yingying Wang and Denghui Deng have contributed to this work equally.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Chun Gui, Email: 3001@hbucm.edu.cn.</p>
<p>Fei Liao, Email: feiliao@whu.edu.cn.</p>
<p>Meixian Xiang, Email: 756616131@qq.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–606. 10.1016/j.jhep.2022.08.021.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2022.08.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9670241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36208844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rumgay%20H,%20Arnold%20M,%20Ferlay%20J,%20Lesi%20O,%20Cabasag%20CJ,%20Vignat%20J,%20Laversanne%20M,%20McGlynn%20KA,%20Soerjomataram%20I.%20Global%20burden%20of%20primary%20liver%20cancer%20in%202020%20and%20predictions%20to%202040.%20J%20Hepatol.%202022;77(6):1598%E2%80%93606.%2010.1016/j.jhep.2022.08.021." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Draper A. A concise review of the changing landscape of hepatocellular carcinoma. Am J Manag Care. 2020;26(10 Suppl):S211-s219. 10.37765/ajmc.2020.88512.
</cite> [<a href="https://doi.org/10.37765/ajmc.2020.88512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33052638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Draper%20A.%20A%20concise%20review%20of%20the%20changing%20landscape%20of%20hepatocellular%20carcinoma.%20Am%20J%20Manag%20Care.%202020;26(10%20Suppl):S211-s219.%2010.37765/ajmc.2020.88512." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Wu K, Lin F. Lipid metabolism as a potential target of liver cancer. J Hepatocell Carcinoma. 2024;11:327–46. 10.2147/jhc.S450423.
</cite> [<a href="https://doi.org/10.2147/JHC.S450423" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10875169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38375401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20K,%20Lin%20F.%20Lipid%20metabolism%20as%20a%20potential%20target%20of%20liver%20cancer.%20J%20Hepatocell%20Carcinoma.%202024;11:327%E2%80%9346.%2010.2147/jhc.S450423." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Corn KC, Windham MA, Rafat M. Lipids in the tumor microenvironment: from cancer progression to treatment. Prog Lipid Res. 2020;80: 101055. 10.1016/j.plipres.2020.101055.
</cite> [<a href="https://doi.org/10.1016/j.plipres.2020.101055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7674189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32791170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corn%20KC,%20Windham%20MA,%20Rafat%20M.%20Lipids%20in%20the%20tumor%20microenvironment:%20from%20cancer%20progression%20to%20treatment.%20Prog%20Lipid%20Res.%202020;80:%20101055.%2010.1016/j.plipres.2020.101055." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Alannan M, Fayyad-Kazan H, Trézéguet V, Merched A. Targeting Lipid Metabolism in Liver Cancer. Biochemistry. 2020;59(41):3951–64. 10.1021/acs.biochem.0c00477.
</cite> [<a href="https://doi.org/10.1021/acs.biochem.0c00477" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32930581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alannan%20M,%20Fayyad-Kazan%20H,%20Tr%C3%A9z%C3%A9guet%20V,%20Merched%20A.%20Targeting%20Lipid%20Metabolism%20in%20Liver%20Cancer.%20Biochemistry.%202020;59(41):3951%E2%80%9364.%2010.1021/acs.biochem.0c00477." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2020;31(1):62–76. 10.1016/j.cmet.2019.11.010.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2019.11.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31813823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Snaebjornsson%20MT,%20Janaki-Raman%20S,%20Schulze%20A.%20Greasing%20the%20wheels%20of%20the%20cancer%20machine:%20the%20role%20of%20lipid%20metabolism%20in%20cancer.%20Cell%20Metab.%202020;31(1):62%E2%80%9376.%2010.1016/j.cmet.2019.11.010." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4–22. 10.1038/s41416-019-0650-z.
</cite> [<a href="https://doi.org/10.1038/s41416-019-0650-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6964678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31819192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koundouros%20N,%20Poulogiannis%20G.%20Reprogramming%20of%20fatty%20acid%20metabolism%20in%20cancer.%20Br%20J%20Cancer.%202020;122(1):4%E2%80%9322.%2010.1038/s41416-019-0650-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Kim DH, Song NY, Yim H. Targeting dysregulated lipid metabolism in the tumor microenvironment. Arch Pharm Res. 2023;46(11–12):855–81. 10.1007/s12272-023-01473-y.
</cite> [<a href="https://doi.org/10.1007/s12272-023-01473-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10725365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38060103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DH,%20Song%20NY,%20Yim%20H.%20Targeting%20dysregulated%20lipid%20metabolism%20in%20the%20tumor%20microenvironment.%20Arch%20Pharm%20Res.%202023;46(11%E2%80%9312):855%E2%80%9381.%2010.1007/s12272-023-01473-y." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, Yang JL. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16(1): 103. 10.1186/s13045-023-01498-2.
</cite> [<a href="https://doi.org/10.1186/s13045-023-01498-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10498649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37700339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20HR,%20Wang%20J,%20Wang%20ZJ,%20Xi%20MJ,%20Xia%20BH,%20Deng%20K,%20Yang%20JL.%20Lipid%20metabolic%20reprogramming%20in%20tumor%20microenvironment:%20from%20mechanisms%20to%20therapeutics.%20J%20Hematol%20Oncol.%202023;16(1):%20103.%2010.1186/s13045-023-01498-2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wang T, Zhang X, Shan K, Luo Y, Yu T, Liu Z, Zhai J, Li S, Yin J, Han N. Various crystalline forms of realgar exhibit differentiated anti-abscess and anticancer effects based on a PXRD analysis and biological evaluation. J Ethnopharmacol. 2025;338(Pt3): 119122. 10.1016/j.jep.2024.119122.
</cite> [<a href="https://doi.org/10.1016/j.jep.2024.119122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39557106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20T,%20Zhang%20X,%20Shan%20K,%20Luo%20Y,%20Yu%20T,%20Liu%20Z,%20Zhai%20J,%20Li%20S,%20Yin%20J,%20Han%20N.%20Various%20crystalline%20forms%20of%20realgar%20exhibit%20differentiated%20anti-abscess%20and%20anticancer%20effects%20based%20on%20a%20PXRD%20analysis%20and%20biological%20evaluation.%20J%20Ethnopharmacol.%202025;338(Pt3):%20119122.%2010.1016/j.jep.2024.119122." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Qian X, Wang Y, Liu Z, Fang F, Ma Y, Zhou L, Pan Y, Meng X, Yan B, Zhu X, Wang X, Zhao J, Liu S. Establishment of XRD fourier fingerprint identification method of realgar decoction pieces and its anti-tumor activity in tumor-in-situ transplanted mice. J Ethnopharmacol. 2024;331: 118303. 10.1016/j.jep.2024.118303.
</cite> [<a href="https://doi.org/10.1016/j.jep.2024.118303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38734390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qian%20X,%20Wang%20Y,%20Liu%20Z,%20Fang%20F,%20Ma%20Y,%20Zhou%20L,%20Pan%20Y,%20Meng%20X,%20Yan%20B,%20Zhu%20X,%20Wang%20X,%20Zhao%20J,%20Liu%20S.%20Establishment%20of%20XRD%20fourier%20fingerprint%20identification%20method%20of%20realgar%20decoction%20pieces%20and%20its%20anti-tumor%20activity%20in%20tumor-in-situ%20transplanted%20mice.%20J%20Ethnopharmacol.%202024;331:%20118303.%2010.1016/j.jep.2024.118303." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Kim SY, Park C, Kim MY, Ji SY, Hwangbo H, Lee H, Hong SH, Han MH, Jeong JW, Kim GY, Son CG, Cheong J, Choi YH. ROS-mediated anti-tumor effect of Coptidis Rhizoma against human hepatocellular carcinoma Hep3B cells and xenografts. Int J Mol Sci. 2021. 10.3390/ijms22094797.
</cite> [<a href="https://doi.org/10.3390/ijms22094797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8124566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33946527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20SY,%20Park%20C,%20Kim%20MY,%20Ji%20SY,%20Hwangbo%20H,%20Lee%20H,%20Hong%20SH,%20Han%20MH,%20Jeong%20JW,%20Kim%20GY,%20Son%20CG,%20Cheong%20J,%20Choi%20YH.%20ROS-mediated%20anti-tumor%20effect%20of%20Coptidis%20Rhizoma%20against%20human%20hepatocellular%20carcinoma%20Hep3B%20cells%20and%20xenografts.%20Int%20J%20Mol%20Sci.%202021.%2010.3390/ijms22094797." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Dong S, Xu P, Yang P, Jiao J, Cheng DC, Chen DL. “Huanglianjiedu Decoction” against pancreatic adenocarcinoma proliferation of by downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 signaling pathways. J Evid Based Integr Med. 2024. 10.1177/2515690x241291381.</cite> [<a href="https://doi.org/10.1177/2515690X241291381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11489918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39410848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20S,%20Xu%20P,%20Yang%20P,%20Jiao%20J,%20Cheng%20DC,%20Chen%20DL.%20%E2%80%9CHuanglianjiedu%20Decoction%E2%80%9D%20against%20pancreatic%20adenocarcinoma%20proliferation%20of%20by%20downregulating%20the%20PI3K/AKT/mTOR%20and%20MAPK/ERK1/2%20signaling%20pathways.%20J%20Evid%20Based%20Integr%20Med.%202024.%2010.1177/2515690x241291381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Xiaoxia X, Jing S, Dongbin X, Yonggang T, Jingke Z, Yanying Z, Hulai W. Realgar nanoparticles inhibit migration, invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis. Curr Drug Deliv. 2020;17(2):148–58. 10.2174/1567201817666200115105633.
</cite> [<a href="https://doi.org/10.2174/1567201817666200115105633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31939730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiaoxia%20X,%20Jing%20S,%20Dongbin%20X,%20Yonggang%20T,%20Jingke%20Z,%20Yanying%20Z,%20Hulai%20W.%20Realgar%20nanoparticles%20inhibit%20migration,%20invasion%20and%20metastasis%20in%20a%20mouse%20model%20of%20breast%20cancer%20by%20suppressing%20matrix%20metalloproteinases%20and%20angiogenesis.%20Curr%20Drug%20Deliv.%202020;17(2):148%E2%80%9358.%2010.2174/1567201817666200115105633." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Li M, Shang H, Wang T, Yang SQ, Li L. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression. World J Gastroenterol. 2021;27(10):939–58. 10.3748/wjg.v27.i10.939.
</cite> [<a href="https://doi.org/10.3748/wjg.v27.i10.939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7968131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33776365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20M,%20Shang%20H,%20Wang%20T,%20Yang%20SQ,%20Li%20L.%20Huanglian%20decoction%20suppresses%20the%20growth%20of%20hepatocellular%20carcinoma%20cells%20by%20reducing%20CCNB1%20expression.%20World%20J%20Gastroenterol.%202021;27(10):939%E2%80%9358.%2010.3748/wjg.v27.i10.939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Heravi G, Yazdanpanah O, Podgorski I, Matherly LH, Liu W. Lipid metabolism reprogramming in renal cell carcinoma. Cancer Metastasis Rev. 2022;41(1):17–31. 10.1007/s10555-021-09996-w.
</cite> [<a href="https://doi.org/10.1007/s10555-021-09996-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10045462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34741716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heravi%20G,%20Yazdanpanah%20O,%20Podgorski%20I,%20Matherly%20LH,%20Liu%20W.%20Lipid%20metabolism%20reprogramming%20in%20renal%20cell%20carcinoma.%20Cancer%20Metastasis%20Rev.%202022;41(1):17%E2%80%9331.%2010.1007/s10555-021-09996-w." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Raskov H, Gaggar S, Tajik A, Orhan A, Gögenur I. Metabolic switch in cancer - survival of the fittest. Eur J Cancer. 2023;180:30–51. 10.1016/j.ejca.2022.11.025.
</cite> [<a href="https://doi.org/10.1016/j.ejca.2022.11.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36527974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raskov%20H,%20Gaggar%20S,%20Tajik%20A,%20Orhan%20A,%20G%C3%B6genur%20I.%20Metabolic%20switch%20in%20cancer%20-%20survival%20of%20the%20fittest.%20Eur%20J%20Cancer.%202023;180:30%E2%80%9351.%2010.1016/j.ejca.2022.11.025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Cui MY, Yi X, Zhu DX, Wu J. The role of lipid metabolism in gastric cancer. Front Oncol. 2022;12: 916661. 10.3389/fonc.2022.916661.
</cite> [<a href="https://doi.org/10.3389/fonc.2022.916661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9240397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35785165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20MY,%20Yi%20X,%20Zhu%20DX,%20Wu%20J.%20The%20role%20of%20lipid%20metabolism%20in%20gastric%20cancer.%20Front%20Oncol.%202022;12:%20916661.%2010.3389/fonc.2022.916661." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Cheng H, Wang M, Su J, Li Y, Long J, Chu J, Wan X, Cao Y, Li Q. Lipid metabolism and cancer. Life (Basel). 2022. 10.3390/life12060784.
</cite> [<a href="https://doi.org/10.3390/life12060784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9224822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35743814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20H,%20Wang%20M,%20Su%20J,%20Li%20Y,%20Long%20J,%20Chu%20J,%20Wan%20X,%20Cao%20Y,%20Li%20Q.%20Lipid%20metabolism%20and%20cancer.%20Life%20(Basel).%202022.%2010.3390/life12060784." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Li B, Mi J, Yuan Q. Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism. Cell Death Discov. 2024;10(1): 350. 10.1038/s41420-024-02126-9.
</cite> [<a href="https://doi.org/10.1038/s41420-024-02126-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11300464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39103344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20B,%20Mi%20J,%20Yuan%20Q.%20Fatty%20acid%20metabolism-related%20enzymes%20in%20colorectal%20cancer%20metastasis:%20from%20biological%20function%20to%20molecular%20mechanism.%20Cell%20Death%20Discov.%202024;10(1):%20350.%2010.1038/s41420-024-02126-9." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12(2):558–80. 10.1016/j.apsb.2021.09.019.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2021.09.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8897153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35256934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20D,%20Liu%20C,%20Qin%20M,%20Zhang%20X,%20Xi%20T,%20Yuan%20S,%20Hao%20H,%20Xiong%20J.%20Metabolic%20dysregulation%20and%20emerging%20therapeutical%20targets%20for%20hepatocellular%20carcinoma.%20Acta%20Pharm%20Sin%20B.%202022;12(2):558%E2%80%9380.%2010.1016/j.apsb.2021.09.019." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zuo Q, Wu Y, Hu Y, Shao C, Liang Y, Chen L, Guo Q, Huang P, Chen Q. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment. Heliyon. 2024;10(9): e30807. 10.1016/j.heliyon.2024.e30807.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e30807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11101863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38765144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuo%20Q,%20Wu%20Y,%20Hu%20Y,%20Shao%20C,%20Liang%20Y,%20Chen%20L,%20Guo%20Q,%20Huang%20P,%20Chen%20Q.%20Targeting%20lipid%20reprogramming%20in%20the%20tumor%20microenvironment%20by%20traditional%20Chinese%20medicines%20as%20a%20potential%20cancer%20treatment.%20Heliyon.%202024;10(9):%20e30807.%2010.1016/j.heliyon.2024.e30807." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Cheng Y, He J, Zuo B, He Y. Role of lipid metabolism in hepatocellular carcinoma. Discov Oncol. 2024;15(1): 206. 10.1007/s12672-024-01069-y.
</cite> [<a href="https://doi.org/10.1007/s12672-024-01069-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11150225/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38833109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20Y,%20He%20J,%20Zuo%20B,%20He%20Y.%20Role%20of%20lipid%20metabolism%20in%20hepatocellular%20carcinoma.%20Discov%20Oncol.%202024;15(1):%20206.%2010.1007/s12672-024-01069-y." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Gagneja S, Capalash N, Sharma P. Hyaluronic acid as a tumor progression agent and a potential chemotherapeutic biomolecule against cancer: a review on its dual role. Int J Biol Macromol. 2024;275(Pt2): 133744. 10.1016/j.ijbiomac.2024.133744.
</cite> [<a href="https://doi.org/10.1016/j.ijbiomac.2024.133744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38986990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gagneja%20S,%20Capalash%20N,%20Sharma%20P.%20Hyaluronic%20acid%20as%20a%20tumor%20progression%20agent%20and%20a%20potential%20chemotherapeutic%20biomolecule%20against%20cancer:%20a%20review%20on%20its%20dual%20role.%20Int%20J%20Biol%20Macromol.%202024;275(Pt2):%20133744.%2010.1016/j.ijbiomac.2024.133744." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Lee JH, Sánchez-Rivera FJ, He L, Basnet H, Chen FX, Spina E, Li L, Torner C, Chan JE, Yarlagadda DVK, Park JS, Sussman C, Rudin CM, Lowe SW, Tammela T, Macias MJ, Koche RP, Massagué J. TGF-β and RAS jointly unmask primed enhancers to drive metastasis. Cell. 2024;187(22):6182-6199.e29. 10.1016/j.cell.2024.08.014.
</cite> [<a href="https://doi.org/10.1016/j.cell.2024.08.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12035776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39243762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20JH,%20S%C3%A1nchez-Rivera%20FJ,%20He%20L,%20Basnet%20H,%20Chen%20FX,%20Spina%20E,%20Li%20L,%20Torner%20C,%20Chan%20JE,%20Yarlagadda%20DVK,%20Park%20JS,%20Sussman%20C,%20Rudin%20CM,%20Lowe%20SW,%20Tammela%20T,%20Macias%20MJ,%20Koche%20RP,%20Massagu%C3%A9%20J.%20TGF-%CE%B2%20and%20RAS%20jointly%20unmask%20primed%20enhancers%20to%20drive%20metastasis.%20Cell.%202024;187(22):6182-6199.e29.%2010.1016/j.cell.2024.08.014." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Fan C, Xiong F, Zhang S, Gong Z, Liao Q, Li G, Guo C, Xiong W, Huang H, Zeng Z. Role of adhesion molecules in cancer and targeted therapy. Sci China Life Sci. 2024;67(5):940–57. 10.1007/s11427-023-2417-3.
</cite> [<a href="https://doi.org/10.1007/s11427-023-2417-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38212458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20C,%20Xiong%20F,%20Zhang%20S,%20Gong%20Z,%20Liao%20Q,%20Li%20G,%20Guo%20C,%20Xiong%20W,%20Huang%20H,%20Zeng%20Z.%20Role%20of%20adhesion%20molecules%20in%20cancer%20and%20targeted%20therapy.%20Sci%20China%20Life%20Sci.%202024;67(5):940%E2%80%9357.%2010.1007/s11427-023-2417-3." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Karalis T, Skandalis SS. Hyaluronan network: a driving force in cancer progression. Am J Physiol Cell Physiol. 2022;323(1):C145-c158. 10.1152/ajpcell.00139.2022.
</cite> [<a href="https://doi.org/10.1152/ajpcell.00139.2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35649255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karalis%20T,%20Skandalis%20SS.%20Hyaluronan%20network:%20a%20driving%20force%20in%20cancer%20progression.%20Am%20J%20Physiol%20Cell%20Physiol.%202022;323(1):C145-c158.%2010.1152/ajpcell.00139.2022." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Suresh MV, Balijepalli S, Solanki S, Aktay S, Choudhary K, Shah YM, Raghavendran K. Hypoxia-inducible factor 1α and its role in lung injury: adaptive or maladaptive. Inflammation. 2023;46(2):491–508. 10.1007/s10753-022-01769-z.
</cite> [<a href="https://doi.org/10.1007/s10753-022-01769-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9811056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36596930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suresh%20MV,%20Balijepalli%20S,%20Solanki%20S,%20Aktay%20S,%20Choudhary%20K,%20Shah%20YM,%20Raghavendran%20K.%20Hypoxia-inducible%20factor%201%CE%B1%20and%20its%20role%20in%20lung%20injury:%20adaptive%20or%20maladaptive.%20Inflammation.%202023;46(2):491%E2%80%93508.%2010.1007/s10753-022-01769-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Fu X, Li X, Wang W, Li J. DPP3 promotes breast cancer tumorigenesis by stabilizing FASN and promoting lipid synthesis. Acta Biochim Biophys Sin (Shanghai). 2024;56(5):805–18. 10.3724/abbs.2024054.
</cite> [<a href="https://doi.org/10.3724/abbs.2024054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11177116/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38655619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20X,%20Li%20X,%20Wang%20W,%20Li%20J.%20DPP3%20promotes%20breast%20cancer%20tumorigenesis%20by%20stabilizing%20FASN%20and%20promoting%20lipid%20synthesis.%20Acta%20Biochim%20Biophys%20Sin%20(Shanghai).%202024;56(5):805%E2%80%9318.%2010.3724/abbs.2024054." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Ward AV, Riley D, Cosper KE, Finlay-Schultz J, Brechbuhl HM, Libby AE, Hill KB, Varshney RR, Kabos P, Rudolph MC, Sartorius CA. Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025;27(1): 32. 10.1186/s13058-025-01991-1.
</cite> [<a href="https://doi.org/10.1186/s13058-025-01991-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11889759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40055794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ward%20AV,%20Riley%20D,%20Cosper%20KE,%20Finlay-Schultz%20J,%20Brechbuhl%20HM,%20Libby%20AE,%20Hill%20KB,%20Varshney%20RR,%20Kabos%20P,%20Rudolph%20MC,%20Sartorius%20CA.%20Lipid%20metabolic%20reprogramming%20drives%20triglyceride%20storage%20and%20variable%20sensitivity%20to%20FASN%20inhibition%20in%20endocrine-resistant%20breast%20cancer%20cells.%20Breast%20Cancer%20Res.%202025;27(1):%2032.%2010.1186/s13058-025-01991-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Huang J, Tsang WY, Fang XN, Zhang Y, Luo J, Gong LQ, Zhang BF, Wong CN, Li ZH, Liu BL, Huang JL, Yang YM, Liu S, Ban LX, Chan YH, Guan XY. FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma. Cancer Res. 2024;84(6):855–71. 10.1158/0008-5472.Can-23-0966.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-23-0966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38486485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20J,%20Tsang%20WY,%20Fang%20XN,%20Zhang%20Y,%20Luo%20J,%20Gong%20LQ,%20Zhang%20BF,%20Wong%20CN,%20Li%20ZH,%20Liu%20BL,%20Huang%20JL,%20Yang%20YM,%20Liu%20S,%20Ban%20LX,%20Chan%20YH,%20Guan%20XY.%20FASN%20inhibition%20decreases%20MHC-I%20degradation%20and%20synergizes%20with%20PD-L1%20checkpoint%20blockade%20in%20hepatocellular%20carcinoma.%20Cancer%20Res.%202024;84(6):855%E2%80%9371.%2010.1158/0008-5472.Can-23-0966." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Kelly W, Diaz Duque AE, Michalek J, Konkel B, Caflisch L, Chen Y, Pathuri SC, Madhusudanannair-Kunnuparampil V, Floyd J, Brenner A. Phase II investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma. Clin Cancer Res. 2023;29(13):2419–25. 10.1158/1078-0432.Ccr-22-2807.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-22-2807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10320469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37093199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kelly%20W,%20Diaz%20Duque%20AE,%20Michalek%20J,%20Konkel%20B,%20Caflisch%20L,%20Chen%20Y,%20Pathuri%20SC,%20Madhusudanannair-Kunnuparampil%20V,%20Floyd%20J,%20Brenner%20A.%20Phase%20II%20investigation%20of%20TVB-2640%20(denifanstat)%20with%20bevacizumab%20in%20patients%20with%20first%20relapse%20high-grade%20astrocytoma.%20Clin%20Cancer%20Res.%202023;29(13):2419%E2%80%9325.%2010.1158/1078-0432.Ccr-22-2807." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Falchook G, Infante J, Arkenau HT, Patel MR, Dean E, Borazanci E, Brenner A, Cook N, Lopez J, Pant S, Frankel A, Schmid P, Moore K, McCulloch W, Grimmer K, O’Farrell M, Kemble G, Burris H. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. EClinicalMedicine. 2021;34: 100797. 10.1016/j.eclinm.2021.100797.
</cite> [<a href="https://doi.org/10.1016/j.eclinm.2021.100797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8040281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33870151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Falchook%20G,%20Infante%20J,%20Arkenau%20HT,%20Patel%20MR,%20Dean%20E,%20Borazanci%20E,%20Brenner%20A,%20Cook%20N,%20Lopez%20J,%20Pant%20S,%20Frankel%20A,%20Schmid%20P,%20Moore%20K,%20McCulloch%20W,%20Grimmer%20K,%20O%E2%80%99Farrell%20M,%20Kemble%20G,%20Burris%20H.%20First-in-human%20study%20of%20the%20safety,%20pharmacokinetics,%20and%20pharmacodynamics%20of%20first-in-class%20fatty%20acid%20synthase%20inhibitor%20TVB-2640%20alone%20and%20with%20a%20taxane%20in%20advanced%20tumors.%20EClinicalMedicine.%202021;34:%20100797.%2010.1016/j.eclinm.2021.100797." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Mukha D, Dessain J, O’Connor S, Pniewski K, Bertolazzi F, Patel J, Mullins M, Schug ZT. Identification of Fasnall as a therapeutically effective complex I inhibitor. bioRxiv. 2024. 10.1101/2024.05.03.592013.
</cite> [<a href="https://doi.org/10.1101/2024.05.03.592013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11100613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38766222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mukha%20D,%20Dessain%20J,%20O%E2%80%99Connor%20S,%20Pniewski%20K,%20Bertolazzi%20F,%20Patel%20J,%20Mullins%20M,%20Schug%20ZT.%20Identification%20of%20Fasnall%20as%20a%20therapeutically%20effective%20complex%20I%20inhibitor.%20bioRxiv.%202024.%2010.1101/2024.05.03.592013." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Ermini L, Driguez P. The application of long-read sequencing to cancer. Cancers (Basel). 2024. 10.3390/cancers16071275.
</cite> [<a href="https://doi.org/10.3390/cancers16071275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11011098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38610953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ermini%20L,%20Driguez%20P.%20The%20application%20of%20long-read%20sequencing%20to%20cancer.%20Cancers%20(Basel).%202024.%2010.3390/cancers16071275." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Archuleta SR, Goodrich JA, Kugel JF. Mechanisms and functions of the RNA polymerase II general transcription machinery during the transcription cycle. Biomolecules. 2024. 10.3390/biom14020176.
</cite> [<a href="https://doi.org/10.3390/biom14020176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10886972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38397413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Archuleta%20SR,%20Goodrich%20JA,%20Kugel%20JF.%20Mechanisms%20and%20functions%20of%20the%20RNA%20polymerase%20II%20general%20transcription%20machinery%20during%20the%20transcription%20cycle.%20Biomolecules.%202024.%2010.3390/biom14020176." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Magnez R, Bailly C, Thuru X. Microscale thermophoresis as a tool to study protein interactions and their implication in human diseases. Int J Mol Sci. 2022. 10.3390/ijms23147672.
</cite> [<a href="https://doi.org/10.3390/ijms23147672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9315744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35887019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Magnez%20R,%20Bailly%20C,%20Thuru%20X.%20Microscale%20thermophoresis%20as%20a%20tool%20to%20study%20protein%20interactions%20and%20their%20implication%20in%20human%20diseases.%20Int%20J%20Mol%20Sci.%202022.%2010.3390/ijms23147672." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Shao W, Sharma R, Clausen MH, Scheller HV. Microscale thermophoresis as a powerful tool for screening glycosyltransferases involved in cell wall biosynthesis. Plant Methods. 2020;16: 99. 10.1186/s13007-020-00641-1.
</cite> [<a href="https://doi.org/10.1186/s13007-020-00641-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7389378/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32742297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shao%20W,%20Sharma%20R,%20Clausen%20MH,%20Scheller%20HV.%20Microscale%20thermophoresis%20as%20a%20powerful%20tool%20for%20screening%20glycosyltransferases%20involved%20in%20cell%20wall%20biosynthesis.%20Plant%20Methods.%202020;16:%2099.%2010.1186/s13007-020-00641-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Zheng D, Zhou Y, Liu Y, Ma L, Meng L. Molecular mechanism investigation on monomer kaempferol of the traditional medicine dingqing tablet in promoting apoptosis of acute myeloid Leukemia HL-60 cells. Evid Based Complement Alternat Med. 2022;2022:8383315. 10.1155/2022/8383315.
</cite> [<a href="https://doi.org/10.1155/2022/8383315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8894007/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35251215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20D,%20Zhou%20Y,%20Liu%20Y,%20Ma%20L,%20Meng%20L.%20Molecular%20mechanism%20investigation%20on%20monomer%20kaempferol%20of%20the%20traditional%20medicine%20dingqing%20tablet%20in%20promoting%20apoptosis%20of%20acute%20myeloid%20Leukemia%20HL-60%20cells.%20Evid%20Based%20Complement%20Alternat%20Med.%202022;2022:8383315.%2010.1155/2022/8383315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Li MN, Shen BQ, Lu X, Gao W, Wen SS, Zhang X, Yang H, Li P. An integrated two-step filtering strategy of collision cross-section interval predicting and mass defect filtering for targeted identification of analogues in herbal medicines using liquid chromatography-ion mobility-mass spectrometry. J Chromatogr A. 2021;1657:462572. 10.1016/j.chroma.2021.462572.
</cite> [<a href="https://doi.org/10.1016/j.chroma.2021.462572" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34601257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20MN,%20Shen%20BQ,%20Lu%20X,%20Gao%20W,%20Wen%20SS,%20Zhang%20X,%20Yang%20H,%20Li%20P.%20An%20integrated%20two-step%20filtering%20strategy%20of%20collision%20cross-section%20interval%20predicting%20and%20mass%20defect%20filtering%20for%20targeted%20identification%20of%20analogues%20in%20herbal%20medicines%20using%20liquid%20chromatography-ion%20mobility-mass%20spectrometry.%20J%20Chromatogr%20A.%202021;1657:462572.%2010.1016/j.chroma.2021.462572." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Wang AQ, Yuan QJ, Guo N, Yang B, Sun Y. Research progress on medicinal resources of Coptis and its isoquinoline alkaloids. Zhongguo Zhong Yao Za Zhi. 2021;46(14):3504–13. 10.19540/j.cnki.cjcmm.20210430.103.
</cite> [<a href="https://doi.org/10.19540/j.cnki.cjcmm.20210430.103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34402272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20AQ,%20Yuan%20QJ,%20Guo%20N,%20Yang%20B,%20Sun%20Y.%20Research%20progress%20on%20medicinal%20resources%20of%20Coptis%20and%20its%20isoquinoline%20alkaloids.%20Zhongguo%20Zhong%20Yao%20Za%20Zhi.%202021;46(14):3504%E2%80%9313.%2010.19540/j.cnki.cjcmm.20210430.103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Wu S, Tong L, Liu B, Ai Z, Hong Z, You P, Wu H, Yang Y. Bioactive ingredients obtained from Cortex Fraxini impair interactions between FAS and GPI. Free Radic Biol Med. 2020;152:504–15. 10.1016/j.freeradbiomed.2019.11.022.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2019.11.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31784059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20S,%20Tong%20L,%20Liu%20B,%20Ai%20Z,%20Hong%20Z,%20You%20P,%20Wu%20H,%20Yang%20Y.%20Bioactive%20ingredients%20obtained%20from%20Cortex%20Fraxini%20impair%20interactions%20between%20FAS%20and%20GPI.%20Free%20Radic%20Biol%20Med.%202020;152:504%E2%80%9315.%2010.1016/j.freeradbiomed.2019.11.022." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Povero D, Ahn JC, Arnold J, Udompap P, Ilyas SI, Arab JP. Hepatology Highlights. Hepatology. 2022;76(1):1–2. 10.1002/hep.32567.</cite> [<a href="https://scholar.google.com/scholar_lookup?Povero%20D,%20Ahn%20JC,%20Arnold%20J,%20Udompap%20P,%20Ilyas%20SI,%20Arab%20JP.%20Hepatology%20Highlights.%20Hepatology.%202022;76(1):1%E2%80%932.%2010.1002/hep.32567." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Xiong P, Zhang F, Liu F, Zhao J, Huang X, Luo D, Guo J. Metaflammation in glucolipid metabolic disorders: pathogenesis and treatment. Biomed Pharmacother. 2023;161: 114545. 10.1016/j.biopha.2023.114545.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36948135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiong%20P,%20Zhang%20F,%20Liu%20F,%20Zhao%20J,%20Huang%20X,%20Luo%20D,%20Guo%20J.%20Metaflammation%20in%20glucolipid%20metabolic%20disorders:%20pathogenesis%20and%20treatment.%20Biomed%20Pharmacother.%202023;161:%20114545.%2010.1016/j.biopha.2023.114545." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Wu Y, Lin Y, Xu S, Su D, Yang H, Tang L. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments. Open Med. 2025;20(1): 20251215. 10.1515/med-2025-1215.</cite> [<a href="https://doi.org/10.1515/med-2025-1215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12163577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40520339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Y,%20Lin%20Y,%20Xu%20S,%20Su%20D,%20Yang%20H,%20Tang%20L.%20Mechanisms%20of%20hesperetin%20in%20treating%20metabolic%20dysfunction-associated%20steatosis%20liver%20disease%20via%20network%20pharmacology%20and%20in%20vitro%20experiments.%20Open%20Med.%202025;20(1):%2020251215.%2010.1515/med-2025-1215." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zhou R, Liu Y, Hu W, Yang J, Lin B, Zhang Z, Chen M, Yi J, Zhu C. <em>Lycium barbarum</em> polysaccharide ameliorates the accumulation of lipid droplets in adipose tissue via an ATF6/SIRT1-dependent mechanism. Acta Biochim Biophys Sin (Shanghai). 2024;56(6):844–56. 10.3724/abbs.2024046.
</cite> [<a href="https://doi.org/10.3724/abbs.2024046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11214951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38606478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20R,%20Liu%20Y,%20Hu%20W,%20Yang%20J,%20Lin%20B,%20Zhang%20Z,%20Chen%20M,%20Yi%20J,%20Zhu%20C.%20Lycium%20barbarum%20polysaccharide%20ameliorates%20the%20accumulation%20of%20lipid%20droplets%20in%20adipose%20tissue%20via%20an%20ATF6/SIRT1-dependent%20mechanism.%20Acta%20Biochim%20Biophys%20Sin%20(Shanghai).%202024;56(6):844%E2%80%9356.%2010.3724/abbs.2024046." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Sharma A, Mahur P, Muthukumaran J, Singh AK, Jain M. Shedding light on structure, function and regulation of human sirtuins: a comprehensive review. 3 Biotech. 2023;13(1): 29. 10.1007/s13205-022-03455-1.
</cite> [<a href="https://doi.org/10.1007/s13205-022-03455-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9805487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36597461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharma%20A,%20Mahur%20P,%20Muthukumaran%20J,%20Singh%20AK,%20Jain%20M.%20Shedding%20light%20on%20structure,%20function%20and%20regulation%20of%20human%20sirtuins:%20a%20comprehensive%20review.%203%20Biotech.%202023;13(1):%2029.%2010.1007/s13205-022-03455-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Hollow SE, Johnstone TC. Realgar and arsenene nanomaterials as arsenic-based anticancer agents. Curr Opin Chem Biol. 2023;72: 102229. 10.1016/j.cbpa.2022.102229.
</cite> [<a href="https://doi.org/10.1016/j.cbpa.2022.102229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36413888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hollow%20SE,%20Johnstone%20TC.%20Realgar%20and%20arsenene%20nanomaterials%20as%20arsenic-based%20anticancer%20agents.%20Curr%20Opin%20Chem%20Biol.%202023;72:%20102229.%2010.1016/j.cbpa.2022.102229." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Lu Q, Tang Y, Luo S, Gong Q, Li C. Coptisine, the characteristic constituent from <em>Coptis chinensis</em>, exhibits significant therapeutic potential in treating cancers, metabolic and inflammatory diseases. Am J Chin Med. 2023;51(8):2121–56. 10.1142/s0192415x2350091x.
</cite> [<a href="https://doi.org/10.1142/S0192415X2350091X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37930333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20Q,%20Tang%20Y,%20Luo%20S,%20Gong%20Q,%20Li%20C.%20Coptisine,%20the%20characteristic%20constituent%20from%20Coptis%20chinensis,%20exhibits%20significant%20therapeutic%20potential%20in%20treating%20cancers,%20metabolic%20and%20inflammatory%20diseases.%20Am%20J%20Chin%20Med.%202023;51(8):2121%E2%80%9356.%2010.1142/s0192415x2350091x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Zhang L, Ling Z, Hu Z, Meng G, Zhu X, Tang H. Huanglianjiedu decoction as an effective treatment for oral squamous cell carcinoma based on network pharmacology and experimental validation. Cancer Cell Int. 2021;21(1): 553. 10.1186/s12935-021-02201-6.
</cite> [<a href="https://doi.org/10.1186/s12935-021-02201-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8529748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34674717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Ling%20Z,%20Hu%20Z,%20Meng%20G,%20Zhu%20X,%20Tang%20H.%20Huanglianjiedu%20decoction%20as%20an%20effective%20treatment%20for%20oral%20squamous%20cell%20carcinoma%20based%20on%20network%20pharmacology%20and%20experimental%20validation.%20Cancer%20Cell%20Int.%202021;21(1):%20553.%2010.1186/s12935-021-02201-6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Shodry S, Hasan YTN, Ahdi IR, Ulhaq ZS. Gene targets with therapeutic potential in hepatocellular carcinoma. World J Gastrointest Oncol. 2024;16(12):4543–7. 10.4251/wjgo.v16.i12.4543.
</cite> [<a href="https://doi.org/10.4251/wjgo.v16.i12.4543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11577361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39678796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shodry%20S,%20Hasan%20YTN,%20Ahdi%20IR,%20Ulhaq%20ZS.%20Gene%20targets%20with%20therapeutic%20potential%20in%20hepatocellular%20carcinoma.%20World%20J%20Gastrointest%20Oncol.%202024;16(12):4543%E2%80%937.%2010.4251/wjgo.v16.i12.4543." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Pang M, Yu L, Li X, Lu C, Xiao C, Liu Y. A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells. Cell Death Dis. 2024;15(8): 562. 10.1038/s41419-024-06956-4.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06956-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11298533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39098929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pang%20M,%20Yu%20L,%20Li%20X,%20Lu%20C,%20Xiao%20C,%20Liu%20Y.%20A%20promising%20anti-tumor%20targeting%20on%20ERMMDs%20mediated%20abnormal%20lipid%20metabolism%20in%20tumor%20cells.%20Cell%20Death%20Dis.%202024;15(8):%20562.%2010.1038/s41419-024-06956-4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Chen Y, Zhong Z, Ruan X, Zhan X, Ding Y, Wei F, Qin X, Yu H, Lu Y. Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1. Dig Liver Dis. 2025;57(3):770–81. 10.1016/j.dld.2024.11.008.
</cite> [<a href="https://doi.org/10.1016/j.dld.2024.11.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39638727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Zhong%20Z,%20Ruan%20X,%20Zhan%20X,%20Ding%20Y,%20Wei%20F,%20Qin%20X,%20Yu%20H,%20Lu%20Y.%20Novel%20biomarker%20in%20hepatocellular%20carcinoma:%20Stearoyl-CoA%20desaturase%201.%20Dig%20Liver%20Dis.%202025;57(3):770%E2%80%9381.%2010.1016/j.dld.2024.11.008." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Alam M, Alam S, Shamsi A, Adnan M, Elasbali AM, Al-Soud WA, Alreshidi M, Hawsawi YM, Tippana A, Pasupuleti VR, Hassan MI. Bax/Bcl-2 cascade is regulated by the EGFR pathway: therapeutic targeting of non-small cell lung cancer. Front Oncol. 2022;12: 869672. 10.3389/fonc.2022.869672.
</cite> [<a href="https://doi.org/10.3389/fonc.2022.869672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8990771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35402265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alam%20M,%20Alam%20S,%20Shamsi%20A,%20Adnan%20M,%20Elasbali%20AM,%20Al-Soud%20WA,%20Alreshidi%20M,%20Hawsawi%20YM,%20Tippana%20A,%20Pasupuleti%20VR,%20Hassan%20MI.%20Bax/Bcl-2%20cascade%20is%20regulated%20by%20the%20EGFR%20pathway:%20therapeutic%20targeting%20of%20non-small%20cell%20lung%20cancer.%20Front%20Oncol.%202022;12:%20869672.%2010.3389/fonc.2022.869672." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Hu B, Lin JZ, Yang XB, Sang XT. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: a review. Cell Prolif. 2020;53(3): e12772. 10.1111/cpr.12772.
</cite> [<a href="https://doi.org/10.1111/cpr.12772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7106960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32003505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20B,%20Lin%20JZ,%20Yang%20XB,%20Sang%20XT.%20Aberrant%20lipid%20metabolism%20in%20hepatocellular%20carcinoma%20cells%20as%20well%20as%20immune%20microenvironment:%20a%20review.%20Cell%20Prolif.%202020;53(3):%20e12772.%2010.1111/cpr.12772." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Matsushita Y, Nakagawa H, Koike K. Lipid metabolism in oncology: why it matters, how to research, and how to treat. Cancers (Basel). 2021. 10.3390/cancers13030474.
</cite> [<a href="https://doi.org/10.3390/cancers13030474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7865757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33530546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matsushita%20Y,%20Nakagawa%20H,%20Koike%20K.%20Lipid%20metabolism%20in%20oncology:%20why%20it%20matters,%20how%20to%20research,%20and%20how%20to%20treat.%20Cancers%20(Basel).%202021.%2010.3390/cancers13030474." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Halimani N, Nesterchuk M, Tsitrina AA, Sabirov M, Andreichenko IN, Dashenkova NO, Petrova E, Kulikov AM, Zatsepin TS, Romanov RA, Mikaelyan AS, Kotelevtsev YV. Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment. Sci Rep. 2024;14(1): 2797. 10.1038/s41598-024-53089-x.
</cite> [<a href="https://doi.org/10.1038/s41598-024-53089-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10837461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38307876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Halimani%20N,%20Nesterchuk%20M,%20Tsitrina%20AA,%20Sabirov%20M,%20Andreichenko%20IN,%20Dashenkova%20NO,%20Petrova%20E,%20Kulikov%20AM,%20Zatsepin%20TS,%20Romanov%20RA,%20Mikaelyan%20AS,%20Kotelevtsev%20YV.%20Knockdown%20of%20Hyaluronan%20synthase%202%20suppresses%20liver%20fibrosis%20in%20mice%20via%20induction%20of%20transcriptomic%20changes%20similar%20to%204MU%20treatment.%20Sci%20Rep.%202024;14(1):%202797.%2010.1038/s41598-024-53089-x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Wang J, Jordan AR, Zhu H, Hasanali SL, Thomas E, Lokeshwar SD, Morera DS, Alexander S, McDaniels J, Sharma A, Aguilar K, Sarcan S, Zhu T, Soloway MS, Terris MK, Thangaraju M, Lopez LE, Lokeshwar VB. Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma. Cancer Cell Int. 2022;22(1): 421. 10.1186/s12935-022-02818-1.
</cite> [<a href="https://doi.org/10.1186/s12935-022-02818-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9801563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36581895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Jordan%20AR,%20Zhu%20H,%20Hasanali%20SL,%20Thomas%20E,%20Lokeshwar%20SD,%20Morera%20DS,%20Alexander%20S,%20McDaniels%20J,%20Sharma%20A,%20Aguilar%20K,%20Sarcan%20S,%20Zhu%20T,%20Soloway%20MS,%20Terris%20MK,%20Thangaraju%20M,%20Lopez%20LE,%20Lokeshwar%20VB.%20Targeting%20hyaluronic%20acid%20synthase-3%20(HAS3)%20for%20the%20treatment%20of%20advanced%20renal%20cell%20carcinoma.%20Cancer%20Cell%20Int.%202022;22(1):%20421.%2010.1186/s12935-022-02818-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Steen EH, Short WD, Li H, Parikh UM, Blum A, Templeman N, Nagy N, Bollyky PL, Keswani SG, Balaji S. Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation. Drug Deliv. 2021;28(1):422–32. 10.1080/10717544.2021.1886376.
</cite> [<a href="https://doi.org/10.1080/10717544.2021.1886376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7899664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33605181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Steen%20EH,%20Short%20WD,%20Li%20H,%20Parikh%20UM,%20Blum%20A,%20Templeman%20N,%20Nagy%20N,%20Bollyky%20PL,%20Keswani%20SG,%20Balaji%20S.%20Skin-specific%20knockdown%20of%20hyaluronan%20in%20mice%20by%20an%20optimized%20topical%204-methylumbelliferone%20formulation.%20Drug%20Deliv.%202021;28(1):422%E2%80%9332.%2010.1080/10717544.2021.1886376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Zhang X, Zhong Y, Miao Z, Yang Q. Hyaluronic acid promotes hepatocellular carcinoma proliferation by upregulating CD44 expression and enhancing glucose metabolism flux. Int Immunopharmacol. 2025;147: 114035. 10.1016/j.intimp.2025.114035.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2025.114035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39798466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Zhong%20Y,%20Miao%20Z,%20Yang%20Q.%20Hyaluronic%20acid%20promotes%20hepatocellular%20carcinoma%20proliferation%20by%20upregulating%20CD44%20expression%20and%20enhancing%20glucose%20metabolism%20flux.%20Int%20Immunopharmacol.%202025;147:%20114035.%2010.1016/j.intimp.2025.114035." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Weiz G, Molejon MI, Malvicini M, Sukowati CHC, Tiribelli C, Mazzolini G, Breccia JD. Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liver Int. 2022;42(2):444–57. 10.1111/liv.15084.
</cite> [<a href="https://doi.org/10.1111/liv.15084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34800352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weiz%20G,%20Molejon%20MI,%20Malvicini%20M,%20Sukowati%20CHC,%20Tiribelli%20C,%20Mazzolini%20G,%20Breccia%20JD.%20Glycosylated%204-methylumbelliferone%20as%20a%20targeted%20therapy%20for%20hepatocellular%20carcinoma.%20Liver%20Int.%202022;42(2):444%E2%80%9357.%2010.1111/liv.15084." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Wang RY, Yang JL, Xu N, Xu J, Yang SH, Liang DM, Li JZ, Zhu H. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma. World J Gastroenterol. 2024;30(8):919–42. 10.3748/wjg.v30.i8.919.
</cite> [<a href="https://doi.org/10.3748/wjg.v30.i8.919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10950635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38516243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20RY,%20Yang%20JL,%20Xu%20N,%20Xu%20J,%20Yang%20SH,%20Liang%20DM,%20Li%20JZ,%20Zhu%20H.%20Lipid%20metabolism-related%20long%20noncoding%20RNA%20RP11-817I4.1%20promotes%20fatty%20acid%20synthesis%20and%20tumor%20progression%20in%20hepatocellular%20carcinoma.%20World%20J%20Gastroenterol.%202024;30(8):919%E2%80%9342.%2010.3748/wjg.v30.i8.919." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Wang J, Luo LZ, Liang DM, Guo C, Huang ZH, Jian XH, Wen J. Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma. World J Clin Cases. 2023;11(23):5416–29. 10.12998/wjcc.v11.i23.5416.
</cite> [<a href="https://doi.org/10.12998/wjcc.v11.i23.5416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10450380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37637689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Luo%20LZ,%20Liang%20DM,%20Guo%20C,%20Huang%20ZH,%20Jian%20XH,%20Wen%20J.%20Recent%20progress%20in%20understanding%20mitokines%20as%20diagnostic%20and%20therapeutic%20targets%20in%20hepatocellular%20carcinoma.%20World%20J%20Clin%20Cases.%202023;11(23):5416%E2%80%9329.%2010.12998/wjcc.v11.i23.5416." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Loomba R, Mohseni R, Lucas KJ, Gutierrez JA, Perry RG, Trotter JF, Rahimi RS, Harrison SA, Ajmera V, Wayne JD, O’Farrell M, McCulloch W, Grimmer K, Rinella M, Wai-Sun Wong V, Ratziu V, Gores GJ, Neuschwander-Tetri BA, Kemble G. TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: fascinate-1, a randomized, placebo-controlled phase 2a trial. Gastroenterology. 2021;161(5):1475–86. 10.1053/j.gastro.2021.07.025.
</cite> [<a href="https://doi.org/10.1053/j.gastro.2021.07.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34310978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Loomba%20R,%20Mohseni%20R,%20Lucas%20KJ,%20Gutierrez%20JA,%20Perry%20RG,%20Trotter%20JF,%20Rahimi%20RS,%20Harrison%20SA,%20Ajmera%20V,%20Wayne%20JD,%20O%E2%80%99Farrell%20M,%20McCulloch%20W,%20Grimmer%20K,%20Rinella%20M,%20Wai-Sun%20Wong%20V,%20Ratziu%20V,%20Gores%20GJ,%20Neuschwander-Tetri%20BA,%20Kemble%20G.%20TVB-2640%20(FASN%20inhibitor)%20for%20the%20treatment%20of%20nonalcoholic%20steatohepatitis:%20fascinate-1,%20a%20randomized,%20placebo-controlled%20phase%202a%20trial.%20Gastroenterology.%202021;161(5):1475%E2%80%9386.%2010.1053/j.gastro.2021.07.025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Liu J, Lahousse L, Nivard MG, Bot M, Chen L, van Klinken JB, Thesing CS, Beekman M, van den Akker EB, Slieker RC, Waterham E, van der Kallen CJH, de Boer I, Li-Gao R, Vojinovic D, Amin N, Radjabzadeh D, Kraaij R, Alferink LJM, Murad SD, Uitterlinden AG, Willemsen G, Pool R, Milaneschi Y, van Heemst D, Suchiman HED, Rutters F, Elders PJM, Beulens JWJ, van der Heijden A, van Greevenbroek MMJ, Arts ICW, Onderwater GLJ, van den Maagdenberg A, Mook-Kanamori DO, Hankemeier T, Terwindt GM, Stehouwer CDA, Geleijnse JM, t Hart LM, Slagboom PE, van Dijk KW, Zhernakova A, Fu J, Penninx B, Boomsma DI, Demirkan A, Stricker BHC, van Duijn CM. Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas. Nat Med. 2020;26(1):110–7. 10.1038/s41591-019-0722-x.
</cite> [<a href="https://doi.org/10.1038/s41591-019-0722-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31932804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Lahousse%20L,%20Nivard%20MG,%20Bot%20M,%20Chen%20L,%20van%20Klinken%20JB,%20Thesing%20CS,%20Beekman%20M,%20van%20den%20Akker%20EB,%20Slieker%20RC,%20Waterham%20E,%20van%20der%20Kallen%20CJH,%20de%20Boer%20I,%20Li-Gao%20R,%20Vojinovic%20D,%20Amin%20N,%20Radjabzadeh%20D,%20Kraaij%20R,%20Alferink%20LJM,%20Murad%20SD,%20Uitterlinden%20AG,%20Willemsen%20G,%20Pool%20R,%20Milaneschi%20Y,%20van%20Heemst%20D,%20Suchiman%20HED,%20Rutters%20F,%20Elders%20PJM,%20Beulens%20JWJ,%20van%20der%20Heijden%20A,%20van%20Greevenbroek%20MMJ,%20Arts%20ICW,%20Onderwater%20GLJ,%20van%20den%20Maagdenberg%20A,%20Mook-Kanamori%20DO,%20Hankemeier%20T,%20Terwindt%20GM,%20Stehouwer%20CDA,%20Geleijnse%20JM,%20t%20Hart%20LM,%20Slagboom%20PE,%20van%20Dijk%20KW,%20Zhernakova%20A,%20Fu%20J,%20Penninx%20B,%20Boomsma%20DI,%20Demirkan%20A,%20Stricker%20BHC,%20van%20Duijn%20CM.%20Integration%20of%20epidemiologic,%20pharmacologic,%20genetic%20and%20gut%20microbiome%20data%20in%20a%20drug-metabolite%20atlas.%20Nat%20Med.%202020;26(1):110%E2%80%937.%2010.1038/s41591-019-0722-x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Kakati T, Bhattacharyya DK, Kalita JK, Norden-Krichmar TM. Degnext: classification of differentially expressed genes from RNA-seq data using a convolutional neural network with transfer learning. BMC Bioinformatics. 2022;23(1): 17. 10.1186/s12859-021-04527-4.
</cite> [<a href="https://doi.org/10.1186/s12859-021-04527-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8734099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34991439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kakati%20T,%20Bhattacharyya%20DK,%20Kalita%20JK,%20Norden-Krichmar%20TM.%20Degnext:%20classification%20of%20differentially%20expressed%20genes%20from%20RNA-seq%20data%20using%20a%20convolutional%20neural%20network%20with%20transfer%20learning.%20BMC%20Bioinformatics.%202022;23(1):%2017.%2010.1186/s12859-021-04527-4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–12. 10.1093/nar/gkaa1074.
</cite> [<a href="https://doi.org/10.1093/nar/gkaa1074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7779004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33237311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Szklarczyk%20D,%20Gable%20AL,%20Nastou%20KC,%20Lyon%20D,%20Kirsch%20R,%20Pyysalo%20S,%20Doncheva%20NT,%20Legeay%20M,%20Fang%20T,%20Bork%20P,%20Jensen%20LJ,%20von%20Mering%20C.%20The%20STRING%20database%20in%202021:%20customizable%20protein-protein%20networks,%20and%20functional%20characterization%20of%20user-uploaded%20gene/measurement%20sets.%20Nucleic%20Acids%20Res.%202021;49(D1):D605%E2%80%9312.%2010.1093/nar/gkaa1074." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Jiao L, Tao Y, Ding H, Wu F, Liu Y, Li C, Li F. Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting. 3 Biotech. 2024;14(9): 215. 10.1007/s13205-024-04053-z.
</cite> [<a href="https://doi.org/10.1007/s13205-024-04053-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11358563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39220827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiao%20L,%20Tao%20Y,%20Ding%20H,%20Wu%20F,%20Liu%20Y,%20Li%20C,%20Li%20F.%20Bioinformatics%20analysis%20of%20BTK%20expression%20in%20lung%20adenocarcinoma:%20implications%20for%20immune%20infiltration,%20prognostic%20biomarkers,%20and%20therapeutic%20targeting.%203%20Biotech.%202024;14(9):%20215.%2010.1007/s13205-024-04053-z." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Cheng B, Tian J, Chen Y. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma. Aging (Albany NY). 2021;13(12):16124–43. 10.18632/aging.203139.
</cite> [<a href="https://doi.org/10.18632/aging.203139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8266373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34133325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20B,%20Tian%20J,%20Chen%20Y.%20Identification%20of%20RNA%20binding%20protein%20interacting%20with%20circular%20RNA%20and%20hub%20candidate%20network%20for%20hepatocellular%20carcinoma.%20Aging%20(Albany%20NY).%202021;13(12):16124%E2%80%9343.%2010.18632/aging.203139." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Sarkar A, Santoro J, Di Biasi L, Marrafino F, Piotto S. YAMACS: a graphical interface for GROMACS. Bioinformatics. 2022;38(19):4645–6. 10.1093/bioinformatics/btac573.
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btac573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35997557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sarkar%20A,%20Santoro%20J,%20Di%20Biasi%20L,%20Marrafino%20F,%20Piotto%20S.%20YAMACS:%20a%20graphical%20interface%20for%20GROMACS.%20Bioinformatics.%202022;38(19):4645%E2%80%936.%2010.1093/bioinformatics/btac573." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Tso SC, Brautigam CA. Measuring the K(D) of protein-ligand interactions using microscale thermophoresis. Methods Mol Biol. 2021;2263:161–81. 10.1007/978-1-0716-1197-5_6.
</cite> [<a href="https://doi.org/10.1007/978-1-0716-1197-5_6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33877597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tso%20SC,%20Brautigam%20CA.%20Measuring%20the%20K(D)%20of%20protein-ligand%20interactions%20using%20microscale%20thermophoresis.%20Methods%20Mol%20Biol.%202021;2263:161%E2%80%9381.%2010.1007/978-1-0716-1197-5_6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12370617/bin/13659_2025_540_MOESM1_ESM.csv" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (96.1KB, csv) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12370617/bin/13659_2025_540_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2.</a><sup> (57.4KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data will be made available on request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Natural Products and Bioprospecting are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s13659-025-00540-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13659_2025_Article_540.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (9.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370617/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370617/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370617%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370617/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370617/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370617/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40839202/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370617/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40839202/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370617/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370617/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="mvmCq6W0AuVgp0lgvqgoAxeqTc6LharqFnCbTbn7QMTYZ3BPVv5G4Bzf6iTAyDsT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
